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Abstract 
This thesis describes the development of a food safety risk assessment framework 
for the Australian dairy industry, through the collection of specific information regarding 
that industry and its collation and organisation into a structured and flexible spreadsheet 
model. The risk assessment model framework was developed for use as a tool for 
evaluating, identifying and prioritising research needs. Developed in Excel (Microsoft 
Corp.) with @Risk (Palisade Corp.) as an add-in, the model uses a stochastic approach 
to evaluate the likely concentration of hazards that may be present in liquid milk. Those 
hazards include: Escherichia coli, Listeria monocytogenes, Salmonella spp., 
Campylobacter spp., Staphylococcus aureus and Yersinia enterocolitica, Bacillus 
cereus, antibiotic and herbicide residues. The structure of the model allows for multiple 
hazards to be modelled in a single simulation. Flexibility of the spreadsheet model 
allows for manipulation of the input distribution 'parameters. This enables the evaluation 
of the effect on hazard concentration in liquid milk to be determined from specific . 
contamination events at the farm level. The effect of pasteurisation on microbiological 
hazards was examined together with the validity of log-linear thermal inactivation 
kinetics. Model estimates for antibiotic residues show that there is less than 10-3 chance 
of exceeding the MRL when starting with an initial probability of 0.0016 that each cow 
is contaminated and 0.1 grams of residue is present in milk from each contaminated 
cow. Microbiological hazards are not expected to survive pasteurisation given the 
estimated concentrations of those hazards entering the milk supply from the farm level 
and the reliability of the pasteurisation process. 
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1. Literature Review 
1.1 Introduction 
The trend in the incidence of food borne illness (FBI) in developed countries is, at 
present, unclear. The US Centre for Disease Control (CDC) has recently reported a 
decrease in the proportion of FBI attributed to bacterial infection for the year 2001 
(CDC, 2002). However, in general FBI has been increasing over the last 10-20 years 
(CDN, 2000). The increase in illness could be an artefact of better epidemiological data, 
better diagnostic techniques (including laboratory tests) or a true increase in the number 
of pathogenic organisms present in foods. Due to the increase in illness, various 
governmental, international and industry organisations are targeting the cause of the 
increase. 
FBI causes economic and social consequences, and with changes in social trends, 
e.g. increased reliance of consumers on other people to prepare food, attempts at curbing 
the increase in FBI have led to new areas of research, including processing and 
production changes, the widespread implementation of hazard analysis and critical 
control point (HACCP) scheme on a larger scale and also the increasing emphasis on 
Risk Assessment, and in particular food safety risk assessments. 
Risk assessment is a field of science that has grown in recognition and use over 
the last 30 years. It has application in many disciplines including: medicine, finance, 
cancer research, computing and microbiology (Haas et al, 1993; Soh et al, 1995; Brown 
et al, 1998; Cassin et al, 1998; Smith 1988)). Risk assessment is an applied science 
formed by the confluence of several disciplines. Risk assessment in microbial food 
safety therefore involves elements of microbiology, epidemiology, statistics, computing; 
pathobiology etc. In the management of food supply, risk assessment has been adopted 
as a structured process for organising scientific knowledge about hazards, so that 
inferences can be made about the likelihood of a particular food safety event occurring 
because of ingestion of a hazard and the impact of this in terms of severity of illness or 
some social or economic measure of consequence. The assessment may be either 
qualitative, where data is lacking and value judgements are required, or quantitative when 
there is sufficient data to describe the process mathematically and the likelihood of 
events described in terms of numerical estimates of probability (Waltner-Toews and 
McEwen, 1994a). The estimate of the probability of those events should include the 
variability and uncertainty of those estimates based on the information available 
- ' 
regarding the events (Nauta, 2000). 
The methodological basis of risk assessment has undergone close scrutiny in the 
last decade. Several approaches have been developed to provide consistency to the risk 
assessment process within each field of application. The International Life Sciences 
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Institute (ILSI, 2000) and the Codex Alimentarius Commission (CAC, 1998) have 
developed standardised frameworks for conducting microbial food safety risk 
assessments. The US Environmental Protection Agency has developed a framework for 
environmental risk assessments (EPA, 1998), and the Office International des Epizooties 
(OIE, 1998) has developed a risk assessment framework for appraising the risk of 
hazards to animal, plant and human health in imported foods and agricultural 
commodities. These frameworks are not intended to be absolute rules; rather they are 
aimed at being useful guidelines that cover the key aspects within the risk assessment 
process. 
The concurrent existence of several frameworks for performing risk assessments 
creates potential for confusion. However the approach adopted by each framework is 
fundamentally the same, there being minor differences in detail. To avoid confusion 
arising from terminology this document adopts the framework and definition proffered 
by the Codex Alimentarius Commission (CAC, 1998). These have been implemented 
during international collaborations of scientists performing a range of risk assessments 
of pathogens in foods (USDA/FSIS, 1998; WHO/FAO, 2001) and therefore have the 
most credibility to adopt as a standard. The definitions are as follows: 
Hazard Identification: The identification of chemical, microbiological or physical 
agents that may cause adverse health affects in humans through the consumption of, or 
exposure to, a particular food product or type. 
Hazard Characterisation: A qualitative or quantitative description of the nature of 
the adverse reaction associated with the chemical, microbiological and physical hazards 
that may be present in the food. 
Exposure Assessment: The qualitative or quantitative estimate of the likely intake 
of chemical, microbiological or physical hazards through the consumption of food, or 
other routes if applicable. 
Risk Characterisation: The qualitative or quantitative evaluation of the probability, 
including uncertainty, of the potential harm and the severity of that harm to the health of 
the consuming population based on the above steps. 
These four steps form the basis of risk assessments designed to comply with the 
internationally accepted approach proffered by the World Health Organisation (WHO) 
and the Food and Agriculture Organisation (FAO; CAC, 1998). Individual risk 
assessments may differ in the detail of the approach taken, but in broad terms comply 
with the above structure and process. To clarify the application of the above process 
when dealing with a food borne hazard a more detailed explanation of each step in risk 
assessment is provided in the following sections. 
Literature Review 9 
1.2 Risk Communication 
Risk communication is as vital to the success of a risk analysis as the four 
components of risk assessment. Regardless of how accurate and reliable the prediction 
that the risk assessment provides, if decision and policy makers do not understand what 
those predictions mean and what their limits are then problems may arise in the 
application of the assessment. Risk communication is an interactive exchange of ideas, 
information and opinions between the risk managers and the risk assessors and the 
stakeholders (i.e. those affected by the risk), which should occur throughout the 
assessment process. This is not a once off process. There should be continual 
interaction and communication throughout the risk assessment process (Notermans et al, 
1999). 
1.3 Risk Management 
With adequate communication of the findings of a risk assessment the final step 
in the process may occur; the management of those risks identified during the 
assessment, taking into account the current policy and regulations that exist (Notermans 
et al, 1999). This falls outside the hands of the scientific community and into the realm 
of the regulators and policy makers. There are three effects that may be brought about, 
although not exclusively: the managers decide to do nothing; action is taken to reduce 
the risks identified in the assessment, or initiation of further research. The first of these 
may be considered a frustrating outcome, however, having established the conditions that 
enable a particular risk from a hazard(s) to arise, any change in those conditions may be 
monitored and at a later date some action may be made. The second, would generally 
arise if the risk was considered by the managers to be too great, hence the need to take 
action to reduce it. The third acknowledges that even the most carefully constructed risk 
assessment contains untested assumptions that may be erroneous or simply critical to 
the outcome, and usually will have identified data gaps in our knowledge of a process 
that, if available, would enable a clearer picture to be obtained. 
It cannot be stressed enough that during the development of the risk assessment 
the scientist(s) conducting the RA should remain unbiased, and any value based 
judgements and assumptions should be explicitly stated. The scientist should also have 
in mind a broad view of the assessment and not just focus on quantification. It is for 
this reason that there is required some kind of mediation between the policy makers, the 
scientific community and the public, that public concern is taken into account. This 
stands well with the concept of the risk assessment process, which at its ultimate end 
aims to reduce the risk of a particular hazard causing undue illness or death. 
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1.4 Uncertainty 
With any attempt to determine the amount of hazard, especially microbiological, at 
the point of consumption one must consider the variability inherent in the process. 
Delignette-Muller and Rosso (2000) showed that both uncertainty and variability should 
be accounted for in any attempt to analyse the degree of exposure to Bacillus cereus in 
pasteurised milk at the point of consumption. Any ~odel that is used to describe the 
process of growth and, or inactivation should address both uncertainty and variability 
(Nauta, 2000; WHO/FAO, 2002). 
Before a risk assessment on a particular pathogen can be produced, extensive 
knowledge of the organism is required including: growth rates, optimal conditions, 
effects of bacteriostatic and bacteriocidal agents and ability to grow and or produce 
toxins in food. All these aspects produce a profile of the pathogen, and with this 
information a clearer picture can be gained as to the foods in which the bacterium is 
likely to survive and/or grow. 
A large part of producing a risk assessment is the ability to describe all the aspects 
of the risk in terms of mathematical functions, to give a numerical value to the risk. The 
form that this takes is a model that can be either deterministic or stochastic. A 
deterministic model uses point estimates rather than a range of possible values and their 
associated probabilities as are used in stochastic modelling. From this background it is 
possible to make decisions that can affect a wide range of areas, from the incidence of 
illness to the introduction of diseases to a "clean" area. The latter point is especially 
pertinent with the current efforts to open trade between all countries in the world and to 
have a global standard for food (ICMSF, 1998). 
The biggest stumbling bock for the evaluation of potential sources of 
contamination and the degree of that contamination is a lack of reliable and detailed data 
(Jaykus, 1996). However, as with other problems regarding a lack of data, a qualitative 
estimate may sometimes be used rather than a quantitative one. 
1.5 Stochastic Modelling 
A food safety risk assessment model attempts to estimate the likelihood and 
magnitude of an adverse health effect (Lammerding, 1997). A value can be placed on the 
relative risk of a particular pathogen being present and causing illness through the use of 
a mathematical model. Moreover that value may be a single point estimate, usually the 
mean, i.e. deterministic, or a range of possible values, stochastic (Vose, 1998). The 
difference between these two approaches is the exclusion or inclusion of variability into 
the estimate. Variability is an inherent aspect in risk assessment, closely tied both to the 
microbial and human populations, and what happens to those populations over time 
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(Buchanan et al, 2000). However, there is also an amount of information that is not 
known nor can ever be known. This is uncertainty. There are three types of models that 
may be used when attempting to model a system, primary, secondary and tertiary. 
Tertiary models are beyond the scope of this project. Primary models describe the effect 
of a single variable on the system, e.g. temperature on the rate of growth of 
microorganisms (van Gerwen and Zwietering, 1998). Secondary models attempt to 
include both variable and uncertain aspects of a process into the model, thus in this 
example giving a range of values for the growth rate at a specified temperature. A large 
part of stochastic modelling is to reduce the uncertainty, and more accurately describe 
variability (Cassin et al, 1998). 
The range of possible values that any particular variable can take is described by a 
distribution function in stochastic models. As with the type of model used, distribution 
functions can be either discrete, taking only a set of specific values, or continuous, 
having a range of real values (Vose, 1998). Determining the result of mathematical 
operations between distribution functions is not an easy task, requiring a deep 
understanding of the mathematics behind the functions 01 ose, 2000). To overcome the 
problem of the difficulty in working with distribution functions, stochastic modelling 
uses sampling from within each distribution to obtain a final predicted value. A process 
automated by computer software. Hence the final output of a stochastic model is limited 
by the technique used to sample the range of distributions for each variable and the 
number of samples taken. The more samples used, the better the accuracy of the 
predicted values. Two commonly used sampling methods that can be used to produce a 
predicted value from a model are Monte-Carlo and Latin Hypercube (Vose, 1998; 
Cassin et al, 1998). The Monte-Carlo sampling technique takes random samples from 
the entire distribution of possible values, whereas Latin Hypercube sampling divides the 
distribution into equal parts and takes an equal number of samples from each part of the 
distribution. In both cases the distribution function will be re-created with sufficient 
iterations, although the Latin Hypercube technique will take fewer iterations than the 
Monte-Carlo technique (Vose, 1996). An iteration in a stochastic model is selection of a 
single sample from each of the distributions in that model. 
With modelling it is, in a limited way, possible to know the future, or at the least 
put it between the bounds of mathematically derived confidence limits. A model is 
useless if it fails to produce predicted values that are similar to known, observed values. 
A saying goes: garbage in, garbage out, and is applicable to modelling. What this means 
is, if the inputs for a model do not reflect the real or observed range of values, then the 
model will produce a worthless output. For this reason a large part of producing a 
model is to elucidate the range of possible values for each variable prior to constructing 
the model itself. 
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1.6 Hazard Identification 
A hazard can be defined as an agent which is either infectious or otherwise that 
may cause an adverse health effect. In food safety, a hazard is a contaminant of or an 
element of the food itself. The hazard in food may cause an adverse health affects when 
ingested by a person. Hence, there is a very broad range of hazards that may possibly 
be present in a particular food. Comprehensive assessment of all the risks for a 
particular food product may thus be very time consuming and difficult and most risk 
assessments consider a subset of the possible classes of hazards. 
There are three main groups of hazard that may be found in foods, these include 
microbiological, chemical, and physical. A fourth group, product tampering, may be 
included although this should be classed as a risk as the tampering will affect the level of 
hazard in the product. This risk falls outside the scope of this risk assessment, however 
it should not be discounted entirely due to potentially disastrous effects. The reader 
should be aware that this is another source of contamination of the product. 
Hazard identification is mainly a qualitative evaluation of the risk issues being 
estimated in the risk assessment. For microbial risk assessment hazard identification is 
often a straightforward task as the agents responsible for causing adverse reaction are 
well described and their effects on consumers can be measured in terms of hours or 
days (Lammerding and Fazil, 2000). Hazard identification for microbial pathogens is 
more focussed on determining those organisms that are likely to be present in the 
product of concern, in this case dairy products, rather than determining if there is a 
possible health effect induced from the ingestion of the organism (Lammerding, 1997). 
Chemicals, however, represent a seemingly inexhaustible supply of hazards. Moreover 
the effects of these contaminants in foods on the exposed population is usually 
measured in terms of years or lifetimes, making the evaluation of the risk from these 
hazards a difficult task. As a result there have been risk assessments performed for 
single chemical hazards to determine whether they have a heal~ effect (Waltner-Toews 
et al, 1994a; Welp and Brummer, 1997). 
van Gerwen (2000) provides a list of potential ·pathogens that may be present in 
liquid milk. The list contains the major pathogens, that is, those widely recognised and 
notable for their disease causing abilities, and minor ones, that is opportunistic 
pathogens that would normally be of little concern except to those with a predisposing 
factor such as a compromised immune system. The list of potential pathogens was 
compiled by using a set of defined "knowledge rules". Those rules reconciled the 
physiological requirements each potential pathogen has for its survival with the physical 
conditions encountered in liquid milk. The use of knowledge rules to identify a range of 
hazards is an acceptable way to begin constructing a list of potential pathogens, however, 
the list presented by van Gerwen is large containing over 70 different pathogenic 
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organisms. A description of each of these pathogens would be a lengthy process and 
for several of the organisms listed there is a paucity of information in the published 
literature regarding their characteristics and modes of transmission and virulence. It will 
be noted by the reader that in the Hazard characterisation section (1.3) there are not 70 
organisms described, rather, several of the more significant organisms have been 
highlighted for discussion. 
Hazards identified as being of concern in this study, as elicited from discussions 
with experts and stakeholders in the Australian dairy industry, are shown in decreasing 
order of priority in Table 1.10. Included in the list are some hazards that have not been 
examined in this thesis, as there is insufficient information available to model the health 
risks arising from their occurrence in dairy products. The higher priority hazards are 
described briefly below. 
1. 7 Pathogens of concern in the dairy industry 
Listeria monocytogenes 
monocytogenes is a pathogen of concern, as can be perceived by Australia's and 
the FDA' s policy of "zero tolerance" for the organism in ready-to-eat (RTE) foods 
(Shank et al, 1996; Duffes et al, 1999). It is ubiquitous in the environment, and relatively 
harmless for the majority of people. It does, however, have one of the highest mortality 
rates for all pathogenic bacteria, up to 30% (Gray and Killinger, 1996; Doyle et al, 
1997). Incidence estimates for listeriosis range from 7.1 per million population per year 
in the US (Gellin et al, 1991) to between 0.1 and 11.3 per million per year in Europe 
(Notermans et al, 1998). In Australia there were 60 cases of listeriosis in 2000, ,...,3 cases 
per million population, with two outbreaks of food borne listeriosis with 13 cases in 
Australia between 1980 and 1995 (CDN, 2000). Table 1.1 outlines the main 
characteristics of listeriosis. Several dose response relationships have been developed 
for this pathogen and are outlined in section 1.8, below. 
Escherichia coli 
Escherichia coli 0157:H7 was first recognised as a human pathogen in 1982 
(Riley et al, 1983 ). Its importance as a human pathogen has grown over the last twenty 
years. There are many pathogenic strains of E. coli, each with different disease 
characteristics (Murray et al, 1998). Among the enterohaembrrhagic strains, the so-
called verotoxigenic E. coli (VTEC) or shiga-toxin producing E. coli (STEC) group, E. 
coli 0157:H7 is found predominantly overseas, whereas 0111 is the most common 
strain found Australia, with some 23 cases reported between 1980 and 1995, including 
one death (CDN, 2000). Table 1.2 outlines the main characteristics of 
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enterohaemorrhagic E. coli infections. Dose response relationships have primarily 
focused on E.coli 0157:H7 and there is a lack of information available regarding other 
E. coli strains to produce suitable dose response models. 
Table 1.1 Characteristics of Listeriosis (CDC, 200la) 
Clinical Features Manifestations are host dependent. In elderly and 
immunocompromised persons, sepsis and meningitis are the main 
!Presentations. Pregnant women experience a mild, flu-like illness often 
!followed by foetal loss or bacteraemia and meningitis in their 
111ewboms. Immunocompetent persons may experience acute febrile 
gastroenteritis. 
Etiologic Agent !Listeria monocytogenes 
Incidence !Approximately 3 cases per million population annually in Australia. 
Transmission Contaminated food. Rare cases of nosocomial transmission have been 
Ire ported. 
Risk Groups For invasive disease, immunocompromised individuals, pregnant 
iwomen and their foetuses and neonates, and the elderly. 
Table 1.2 Characteristics of verotoxigenic, or ST E. coli 
infections (CDC, 2001 b) 
Clinical IAcute bloody diarrhoea and abdominal cramps with little ~r no fever; 
Features usually lasts 1 week. 
Etiologic Agent Several, most recognised is Escherichia coli serotype 0157:H7. 
Gram-negative rod-shaped bacterium producing Shiga toxin(s). 
Sequelae Haemolytic uremic syndrome (HUS): People with this illness develop 
kidney failure and often require dialysis and transfusions. Some 
develop chronic kidney failure or neurological impairment (e.g., 
seizures or blindness). Some require surgery to remove part of the 
bowel. Death (estimated 61 fatal cases annually; 3-5% with HUS die). 
Costs Estimated 20 cases annually in the Australia. The illness is often 
misdiagnosed; therefore, expensive and invasive diagnostic procedures 
may be performed. Patients who develop HUS often require 
prolonged hospitalisation, dialysis, and long-term follow-up. 
Transmission Major source is ground beef; other sources include consumption of 
un-pasteurised milk and juice, sprouts, lettuce, and salami, and contact 
with cattle. Waterbome transmission occurs through swimming in 
contaminated lakes, pools, or drinking inadequately chlorinated water. 
Organism is easily transmitted from person to person and has been 
difficult to control in child day-care centres. 
Risk Groups All persons. Children <5 years old and the elderly are more likely to 
develop serious complications. 
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Salmonella 
The genus Salmonellae is now considered to contain a single species, Sabnonella 
enterica, with seven distinct subgroups. This species contains over 2000 serovars all of 
which are capable of causing infection and disease in humans (Murray et al, 1998; Fazil 
et al, 2000). In Australia there were around 5700 reported cases of Salmonellosis in 
total in 2000 (CDN, 2000). Foodbome salmonellosis in Australia, between 1980 and 
1995, caused 27 outbreaks with 1323 cases and one death (CDN, 2000). Table 1.3 
outlines the main characteristics of salmonellosis. This highlights the importance of this 
organism in the food industry, as it covers many food types, countries and situations. 
Teunis et al (1999) reported that one of the biggest complications with modelling the 
dose response relationship for Salmonellae is the difference in strain virulence within the 
species. This strain difference makes it difficult to describe a dose response for 
Salmonellae, because it should be known for which strain the dose response has been 
derived. Consequently several dose response relationships have been developed for this 
pathogen; see section 1.8. 
Table 1.3 Characteristics of Salmonella spp infections (CDC, 
200lc) 
Clinical !Fever, abdominal cramps, and diarrhoea (sometimes bloody). 
Features Occasionally progresses to sepsis. 
Etiologic Agent Enterobacteriaceae of the genus Salmonella. Approximately 2000 
serotypes cause human disease. 
Transmission Contaminated food, water, or contact with infected animals. 
Risk Groups Affects all age groups. Groups at greatest risk for severe or 
complicated disease include infants, the elderly, and persons with 
compromised immune systems. 
Campylobacter jejuni 
Campylobacteriosis is one of the most common causes of intestinal disease 
(Medema et al, 1996) with estimates of incidence ranging between 1-2% in the 
Netherlands (Medema et al, 1996), "'1 % in the US (Tauxe, 1992), and 1.1 % in the UK 
(Kendall and Tanner, 1982). In Australia there were "'12000 notified cases of 
campylobacteriosis in the year 2000. Between 1980 and 1995 there were 5 outbreaks 
involving 109 cases of foodborne campylobacteriosis (CDN, 2000). The majority of 
cases of campylobacteriosis are sporadic. Table 1.4 outlines the main characteristics of 
Campylobacter jejuni infections. Several dose response models have been published, 
these are presented in section 1.8. 
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Table 1.4 Characteristics of Campylobacter jejuni infections (CDC, 2001d) 
Clinical Incubation periods of between 2 and 11 days, 3-5 the most common. 
Features In adults: onset quite fast. Duration "-"<1 week. Recurrence of 
symptoms in 25% of cases (Blaser et al, 1983). In children: vomiting 
in ,_,50% of cases, few patients with abdominal pain. 
Etiologic Agent Campylobacter jejuni and C. coli two most common causes of 
infection with this genus 
Incidence Milk implicated in a large number of infection outbreaks, from small 
localised outbreaks to large ones involving lOO's of people. Incidence 
in raw milk is low 0.4% up to 8.1 % (latter figure is from cattle herds 
known to be infected with Campylobacter). 
Sequelae Symptoms intestinal but sometimes flu-like prodromal period with 
associated malaise, headache, shivering, dizziness and myalgia. 
ntestinal symptoms more pronounced if following a prodrome. 
Diarrhoea - severe and prostrating to a few loose stools. Abdominal 
pain. 
Transmission nfective dose-as few as 500cells and up to 106 have been reported. 
Contamination of milk most likely though faeces. Only been 
associated with liquid milk rather than other dairy products. 
Risk Groups bimodal distribution, in the UK children between 1-4 yrs, and between 
15-24yrs. Male homosexuals at greater risk to Campylobacter 
enteritis. Systemic infections mainly in those with underlying 
predisposition - malignant diseases such as leukaemia, 
immunosuppression, alcoholism, liver cirrhosis, diabetes, chronic renal 
failure and gastrectomony (Skirrow, 1984). Pregnancy is also a risk 
actor (Weinberg, 1984). Excluding pregnancy, systemic infections 
predominantly in males 45yrs or older. 
Bacillus cereus 
Bacillus cereus is a Gram-positive, spore-forming bacterium, found in most 
environments, from soil to the raw ingredients in foods. It is recognised as a food borne 
pathogen and is a significant causative agent in food born illness, due to either of two 
toxins produced by the organism (Dufrenne et al, 1995; Murray et al, 1998). In 
Australia between 1980 and 1995 there were 5 outbreaks of food borne B. cereus 
infections, involving 27 cases (CDN, 2000). More recently the organism has been 
implicated in an outbreak in Victoria (Vic. DHS, 2002). The two toxins produced by B. 
cereus cause differing illness. A heat stable toxin is associated with the emetic form of 
illness, and a heat labile toxin is associated with the diarrhoeal form (Murray et al, 1998). 
Table 1.5 outlines the characteristics of B. cereus intoxications. 
Notermans et al (1997) describe the risk assessment process for B. cereus in 
pasteurised milk. From various sources, they state, that the likely level of the organism 
required to induce symptomatic illness is >105• This is a similar figure to that presented 
by Doyle et al (1997), who indicate that an infectious dose of this organism is between 
105 -107 and 105 -108 will likely induce toxin production in the small intestine and in 
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food, respectively. Those authors did not derive a dose response relationship for the 
organism. A lack of information regarding this organism's ability to induce illness, 
indications that not all strains of B. cereus are toxin producers, and differences between 
the level of organism required to cause either emetic and diarrhoeic illness are 
highlighted as difficulties in developing a suitable dose response relationship for this 
organism. 
Table 1.5 Characteristics of Bacillus cereus infections (adapted from Murray et 
al, 1998). 
Clinical Diarrhoeal and emetic food poisoning a result of two different toxins 
Features 
Etiologic Agent Bacillus cereus - toxin production. · 
Incidence No cases of B. cereus poisoning have been reported for UHT milk, 
but is a common contaminant of dried milk, although the importance 
of this is under debate. 
Sequelae Diarrhoeal - incubation period of 8-16 hours, followed by abdominal 
cramps, and profuse diarrhoea. Vomiting and fever are occasional 
symptoms, recovery usually within 24 hrs. Emetic poisoning short 
incubation of 1-6 hours. Nausea followed by vomiting and malaise, 
recovery generally within 24 hours. 
Transmission Associated with the spoilage of fresh milk, this has changed recently 
!due to the introduction of refrigeration for pasteurised products, and 
!Partly from reduced incidence of contamination of raw materials. Can 
still be readily isolated from pasteurised milk (Christiansson, 1989) 
and cream. Can also be isolated from UHT milk (Mostert et al, 1979; 
MT esthoff and Dougherty, 1981) 
Risk Groups No particular groups are at risk, although the extremes of age and 
immunocompromised would have a relatively higher risk of infection. 
Most commonly associated with large-scale food preparation. 
More complete lists of potential pathogens in dairy products are presented in Boor 
(1997) and van Gerwen (2000). A summary of the characteristics of disease caused by 
some of those organisms is given in Tables 1.6, 1.7, 1.8 and 1.9. 
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Table 1.6 Staphylococcus aureus: characteristics of disease 
Clinical Features Symptoms usually appear within 2-4 hours (Bergdoll, 1979). 
Symptoms generally persist for less than 24 hours 
Etiologic Agent Staphylococcus aureus 
Incidence USA of 131 outbreak and over 7000 cases (Holmberg and Blake, 
1984). Reported cases of staphylococcal food poisoning from cheese 
limited to cheddar and similar varieties (ICMSF, 1980, 1986) and 
Swiss type cheese (Todd et al, 1981). 
Sequelae Nausea, retching, vomiting and less frequently diarrhoea. Fever has 
been found in ,..,16% of cases (Holmberg and Blake, 1984). With 
severe cases - dehydration, shock and collapse, accompanied by 
shallow breathing and weak pulse. Up to 10% of sufferers seek 
medial attention. Death rare. Symptoms may be confused with B. 
cereus emetic infection (Newsome, 1988) 
Transmission Milk from most species including cattle (Harvey and Gilmour, 1985), 
goats and sheep contain S. aureus. Greater numbers in mastitic milk, 
although less marked with this organism than other mastitis causing 
bacteria, S. uberis (Bramley et al, 1984). Presence in raw milk is 
generally not a problem, though from mastitic milk higher numbers of 
enterotoxigenic organisms may be present (Lombai et al, 1980). There 
have been examples of toxin production in milk prior to pasteurisation 
(Holmberg and Blake, 1984). Staphylococcus aureus can be isolated 
from a wide range of fermented milk products, usually in low 
numbers. The greatest numbers is generally in hard cheeses (cheddar 
etc) due predominantly to a poor starter culture. 
Risk Groups Wide variation among normal adults, but greatest susceptibility in the 
young and old. Unhealthy people are at greater risk, but no particular 
predisposing condition for staphyl_ococcal infection. 
Table 1.7 Characteristics of Group A Streptococcal infections (CDC, 2001f) 
Clinical Features Non-invasive disease (strep throat, cellulitis); invasive disease 
(necrotizing fasciitis (NF), streptococcal toxic shock syndrome 
(STSS), bacteraemia, pneumonia); nonsuppurative sequelae (rheumatic 
fever, post-streptococcal glomerulonephritis). STSS is a severe illness 
characterized by shock, multiple organ failure. NF presents with severe 
local pain, destruction of tissue. Rheumatic fever is a leading cause of 
acquired heart disease in young people worldwide. 
Etiologic Agent Group A Streptococcus; STSS and NF occur more often among 
persons infected with group A Streptococcus spp serotypes M-1 and 
M-3 or toxin- producing strains. 
Incidence Approximately 10,000 annual cases of invasive disease (3.7/100,000 
population) occurred in 1998; approximately 5% are STSS and 5%-
8% are NF. Over 10 million noninvasive GAS infections (primarily 
throat and skin infections) occur annually. 
Sequelae Death in 10%-13% of all invasive cases, 45% of STSS, 25% of NF 
cases. Organ system failure (STSS) and amputation (NF) also may 
result. 
Transmission Person to person by contact with infectious secretions. 
Risk Groups Invasive disease: elderly, immunosuppressed, persons with chronic 
cardiac or respiratory disease, diabetes, skin lesions (i.e. children with 
varicella [chicken pox], intravenous drug users) African-Americans, 
American Indians. Noninvasive disease: children (especially 
elementary school age) at highest risk. 
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Table 1.8 Characteristics of Group B Streptococcal infections (CDC, 2001g) 
Clinical Features OCn neonates: sepsis, pneumonia and meningitis. In adults: sepsis and soft 
~issue infections. Pregnancy-related infections: sepsis, amnionitis, 
!Urinary tract infection, and stillbirth. 
Etiologic Agent 
Streptococcus agalactiae or group B streptococcus (GBS). 
Incidence !Approximately 18,000 cases occur annually in the United States; 
approximately 7,500 occurred in newborns before recent prevention. 
[he rate of neonatal infection has decreased from 1.7 cases per 1,000 
Hve births (1993) to 0.6 cases per 1,000 live births (1998). 
Sequelae Neurological sequelae include sight or hearing loss and mental 
retardation. Death occurs in 6% of infants and 16% of adults. 
Transmission !Asymptomatic carriage in gastrointestinal and genital tracts is common. 
fotrapartum transmission via ascending spread from vaginal and/or 
gastrointestinal GBS colonization occurs. Mode of transmission of 
disease in non-pregnant adults is unknown. 
Risk Groups Risk Groups Adults with chronic illnesses (e.g., diabetes mellitus and 
liver failure), pregnant women, the foetus, and the newborn are at risk. 
For neonatal disease, risk is higher among infants born to women with 
OBS colonization, prolonged rupture of membranes or pre-term 
delivery. 
Table 1.9 Characteristics of Yersinia enterocolitica infections (CDC, 2001e) 
Clinical Features Children - fever, abdominal pain, and diarrhoea, which is often bloody. 
!Adults - right-sided abdominal pain and fever. Symptoms develop 
within 4-7 days. Duration of illness 1-3 weeks, maybe longer 
Etiologic Agent Most illness caused by Y. enterocolitica. Y pseudotuberculosis causes 
similar illness though not as common. 
Incidence 1 per 100000 people, more common in children and during winter 
Transmission Animal reservoir primarily pigs, also rodents, rabbits, sheep, cattle, 
horses, dogs, and cats. Contaminated milk or untreated water, contact 
~ith infected animals, faecal-oral infections and rarely through 
contaminated blood 
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Table 1.10 - Ranking of Hazards Associated with Dairy Products 
Hazard Ranking Hazard 
High Enterococci; EHEC/VTEC; Salmonella spp.; Listeria 
monocytogenes; herbicides; aflatoxins . 
Medium Yersinia spp.; Campylobacter spp.; Bacillus cereus; 
Staphylococcus aureus; Cryptosporidium spp; antimicrobials; 
antiparasitics - flukicides and anthelminthics ; mycotoxins 
Pesticides - Organochlorines, Organophosphates and 
pyrethroids 
Low Q Fever; Toxoplasmosis; Brucella abortis; Pseudomonas 
pseudomallei; Clostridium botulinum; Clostridium perfringens; 
BST and other hormones; Blue-green algae; Heavy metals and 
Iodine 
For consideration if Mycobacterium paratuberculosis; Bacillus anthracis; Viruses; 
time is available agent causing bovine spongiform encephalopathy (BSE); 
enzootic bovine leucosis (EBL) 
Of these hazards it was resolved (see section 2.1) that those to be included in the 
risk assessment model be: Escherichia coli, Salmonella spp, Listeria monocytogenes, 
Bacillus cereus, Campylobacter jejuni, Yersinia enterocolitica, antibiotics and herbicides 
in general (there was insufficient information to focus on a particular one). 
1.8 Hazard Characterisation - Dose Response Assessment 
Hazard characterisation, as mentioned previously, is the qualitative or quantitative 
description of the adverse health effects resulting from contact with those hazards 
identified in the hazard identification (Farber et al, 1996; Buchanan et al, 2000). 
Buchanan et al (2000) mentions the infectious disease triangle, stating the importance of 
three aspects of the likelihood of developing illness from a foodbome pathogen. These 
three aspects include the interaction between the host, the pathogen and the food matrix, 
which together determine if illness is manifested in the host. The three points in the 
disease triangle are: 
• The disease causing characteristics of microorganisms; infections, toxico-
infectious or toxigenic. 
• The characteristics of the host; the very young, the old, 
immunocompromised, immune or naive. 
• The food matrix: the food may ·confer some resistance from the host's 
non-specific and immune system defences to the pathogen, it .may either 
hamper or enhance the pathogenicity of the organism. 
A further consideration emerges from Buchanan et al (2000): that of variability 
within each aspecrof the disease triangle. 
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It is not necessary here to describe the wide and varied forms of pathogenicity of 
microbiological hazards or to give a detailed examination of the chemical hazards (This 
alone could constitute a third of this thesis). For clarity, however, a brief discussion of 
the various forms of dose response models that have been developed for both 
microbiological and chemical hazards shall be given, and then an examination of each 
prioritised hazard together with their dose response relationship, if that exists. 
1.8.1 Dose Response Assessment 
Dose response modelling is not a new concept. One journal article, describing 
mathematically the infectivity of the tobacco mosaic virus (Furomoto and Mickey, 1967), 
is more than 30 years old and forms the theoretical basis of many of the models used 
currently. The basis of dose response modelling for food safety risk assessments, th~t 
is determining/predicting human health effects to known levels of hazards in a 
mathematical form, has not changed. There have been a large variety of dose response 
papers published. These consider topics including: cancer research (Edler and Kopp-
Schneider, 1998), chemical safety (Krewski and van Ryzin, 1981; Welp and Brummer, 
1997), microbiology (Buchanan et al, 2000; Haas et al, 2000; Havelaar et al, 2000), water 
safety research (Regli et al, 1991; Haas et al, 1993), discussions on dose response 
modelling (Coleman and Marks, 1998; Buchanan et al, 2000), and papers discussing the 
advantages and disadvantages of different dose response models (Holcomb et al, 1999; 
Teunis and Havelaar, 2000; WHO/FAO, 2002). 
There are many different ways to model the health reaction to the ingestion of 
known hazards. For microbial dose response models there are predominantly two end 
points that are modelled: the probability of infection and the probability of illness. A 
third endpoint that may be mentioned, though rarely modelled, is the probability of 
mortality at a given dose, or it may be presented as severity with mortality included. 
Most studies only examine one of the end points, whereas a few try to make some 
connection between infection and the probability of developing illness from that 
infection. 
Literature Review 22 
Dose Response Modelling Theory 
The aim of dose response modelling is to determine the probability of a defined 
adverse health reaction from the ingestion of a particular hazard. Of the dose response 
models that have been developed, there are two broad categories: those models that 
assume a threshold, below which no infection occurs, and hit-theory models, which 
assume that every individual cell or toxic particle is capable of causing infection in the 
host (Furomoto and Mickey, 1967; Turner, 1975; Coleman and Marks, 1998). Much 
debate over which type of model is the most suitable has occurred. The majority of 
models used are hit-theory models, which are in a class of a larger group of mechanistic 
models. A single hit model assumes that a single particle is capable of causing an 
adverse health reaction. The log-logistic, log-probit and Weibull (-Gamma) models are 
among the hit theory models used (WHO/FAQ, 2002). There has been confusion about 
which models are and are not hit theory models. For example the exponential model 'has 
often been considered a threshold model due to the sigmoidal shape of the response 
curve, which suggests that below some level there is no response, however, Buchanan et 
al (1997) show that when the log is taken of the probability of response, there is a linear 
relationship between the log dose and the log probability. This precludes the possibility 
of a threshold existing for this model. Moreover, for another widely used model, the 
Beta-Poisson model, it has been demonstrated (Teunis and Havelaar, 2000) that although 
it is assumed to be a single hit model, it is not. 
What follows is a brief discussion on the various forms of dose response models 
that exist in the published literature, the relationship between different models, and 
problems associated with each. 
The underlying theme of hit-theory models assumes that each ingested pathogen 
or unit of hazard is capable of causing disease, with some probability (Vose, 1998). 
This is a Binomial process; hence the probability of infection is given by: 
(1) 
Where Pin/ is the probability of infection, n is the amount of hazard ingested 
(trials), and p is the probability that each organism ingested will survive to cause 
infection. 
The simplest of the dose response models that are used in the literature is the 
exponential model. The exponential model assumes that each organism entering the 
host is capable of causing infection, i.e. a single hit is required to cause infection, that 
each ingested cell acts independently of others, and that the organisms are distributed 
randomly throughout the contaminated food. The model is expressed in the form: 
p = 1- e-rd (2) 
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Where r is probability of an individual cell causing infection and d is the dose 
(number of organisms ingested). 
The cells ingested in each dose are assumed to follow a Poisson distribution, 
randomly distributed, and the dose is the mean of the sample taken from that distribution 
(Powell et al, 2000). A further assumption in the exponential model is that r is a 
constant. This represents the host-microbe interaction, or the proportion of organisms 
surviving the host's defences to cause infection (Regli et al, 1991; Powell et al, 2000). 
If r is not a constant, by taking a general case it's value can be approximated 
(Vose, 1998). The Beta-Poisson model does this where it is assumed that r follows a 
Beta distribution (r = Beta(a, b)). This may be explained in terms of the ingested cells 
and the host's immune response. For each individual cell in the dose, each may be 
considered independent, that is they all have equal probability of surviving to cause 
infection once inside the host. However, the number of cells in the dose that survive and 
are able to initiate infection can be described by a Beta distribution (Holcomb et al, 1999; 
Powell et al, 2000). The general form of the Beta-Poisson model is expressed as: 
p = 1- (1 + d/bya (3) 
This only holds for when b is much larger than a, and hence the probability of an 
individual cell causing infection is low (Vose, 1998). The more common form of this is 
to express b in terms of the median effective dose (ED50) or median Infective dose 
(ID50), that is, the number of ingested organisms required to cause infection in half of 
the exposed population, where: 
b = ED50/(211a - 1) (4) 
Hence the Beta-Poisson model (3) can be expressed as: 
P = 1 - (1 + (d/ED50)* (211a - l)ya (5) 
Another approximation of the Beta-Poisson model may be made. Where b 
approaches 0, the model (3) reduces to its Poisson form: 
(6) 
The Beta-Poisson model is a special case of a third, more flexible three-parameter 
model, the Weibull-Gamma model: 
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(7) 
Where a, b and x are parameters affecting the shape of the curve. 
This reduces to the Beta-Poisson model when x = 1. Moreover, the Weibull-
Gamma reduces to the Log-Logistic when a= 1. 
Other models have been used to describe the dose response relationship for 
microbial pathogens. The ge~eral forms for these models are listed in Table 1.11. 
Table 1.11 Dose response models used for microbial pathogens, general form 
Model Parameters Equation 
Logistic alpha, beta eaipna + oeca•m\OOSeJ I 1 + e acpna + oera-m\OOSeJ 
Gompertz - log alpha, beta 1 _ e-eA(alpha + (beta*ln(dose))) 
Gompertz - Power alpha, beta, power 1 _ e-e"(aJpha + (betaApower)) 
Log-Normal (Probit) alpha, beta Normal_cdf(alpha +beta* log10(dose) 
Multihit gamma,k Gamma_cdf(gamma *dose, k) 
cdf = cumulative d1stnbut1on function 
There are several considerations before a dose response model is used to predict 
the probability of a health outcome. Firstly, the model should fit the observed data 
adequately, and it should be as simple as possible (a more parsimonious model is one 
that has fewer fit parameters than another which fits the data equally). The model 
chosen should also be applicable over the range of conditions for the data to which it is 
being applied (Holcomb et al, 1999). In the event that there is no suitable dose response 
model available, with the exception of developing a new one, it has been proposed that 
linear risk extrapolation can often be accepted as the default for dose-response curves 
(Waltner-Toews and McEwen, 1994a). 
Due to the broad range of models and hazards that have had a dose response 
relationship described, the succeeding section details some models that have been 
developed for microbial pathogens and presents a short treatise on the concept of 
chemical dose response assessment. 
I 
1.8.2 Microbial Dose Response Assessment 
There are several pathogens on which a greater amount of risk assessment 
research has been focussed, namely E.coli 0157, Salmonella, Listeria monocytogenes 
and to a lesser extent Campylobacter jejuni. Consequently for these pathogens there are 
several papers that describe dose response models that have been developed. One of the 
basic premises of these models is that at an increasing dose the chance ~f becoming ill 
increases to maximum at some point, that is, the response has an asymptote. 
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For each of the identified microbiological hazards a discussion on the various 
dose response models proposed to describe infectivity curves is presented. There are 
some microbial pathogens that have not had a dose-response curve defined. This is 
mainly due to a lack of data to describe the curve with any degree of certainty. 
Listeria monocytogenes 
Haas et al (1999) developed and validated a dose response relationship for 
infection for Listeria monocytogenes. Data used were based on animal feeding studies 
conducted by Audurier et al (1980) and Golnazarian et al (1989). Haas et al (1999) 
used three different sets of data when fitting the parameters for the dose response 
models. Hass et al (1999) compares the use of the exponential and the Beta-Poisson 
dose response models to fit the data used. Those authors found that the Beta-Poisson 
model had the best fit to all sets of data, including the pooled dataset. A summary of the 
fit parameters is shown for the pooled dose response data (Table 1.12). 
Buchanan et al (1997) developed a risk assessment model for listeriosis using 
German smoked fish data, as an example of the development of purposefully 
conservative risk assessment models based on annual disease statistics and food survey 
data. The dose response model used in that assessment was an exponential dose 
response model with parameter R being as conservative as the data would allow. The R-
value estimated in the paper is defined as the probability that the ingestion of a single cell 
of L. monocytogenes would produce an active case of listeriosis. This approach 
estimates a "worst case", thus allowing the current tolerance to this organism's 
presence in foods to be evaluated. The dose response model was used to estimate an 
adverse health effect, that is morbidity. 
Lindqvist and WestOo (2000) used a similar approach as Buchanan et al (1997) to 
develop a conservative dose response relationship for Listeria monocytogenes based on 
annual disease statistics and food survey data in Sweden. They selected two models: the 
exponential and the Weibull-gamma. The fitted parameters for the exponential model 
are shown in Table 1.8.2.1. The parameter values used in the Weibull-gamma model 
were those estimated by Farber et al (1996). 
Farber et al (1996) developed a dose response model for Listeria monotytogenes 
based on the Weibull Gamma model. The parameter values fitted to the model are not 
presented, however, those authors attempted to distinguish between high and low risk 
populations, through the use of the infectious dose (ID) at two levels, ID10 and ID90• 
The IDn is that dose causing illness in the stated (n) percentage of the population, i.e. in 
the above case, 10% and 90% of the population respectively. 
The United Nation's World Health Organisation (WHO) and the Food and 
Agriculture Organisation (FAO) conducted a risk assessment for Listeria 
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monocytogenes in ready to eat foods (WHO/FAO, 2001). An exponential model was 
used for the dose response relationship, with different parameter values for susceptible 
and less susceptible exposed populations. 
Table 1.8.2.1 Dose response model parameters for Listeria monocytogenes 
Author Model Parameter Value 
Haas et al (1999) Exponential k 1.77 x 104 
Beta-Poisson 0.25 
-
Nso 2.76x102 
Buchanan et al Exponential R 1.179 x io-10 
(1997) 
Lindqvist ad Exponential R 5.6 x 10-10 
Westoo (2000) 
Farber (1996) Weibull-gamma b 1010·98 (high risk) 
1010·26 (low risk) 
WHO/FAO (2001) Exponential R 1.06 x 10-12 (susceptible) 
2.37 x 10-14 (normal) 
N50 s1gmfies the dose at which half the exposed population will become mfected 
R is the probability that the ingestion of a single cell causes the adverse health reaction 
A comparison of the different dose response relationships that have been derived 
for Listeria monocytogenes is shown (Fig 1.1). The curves presented are those that 
could be regenerated from the information presented in the papers listed above. 
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Fig 1.1 Comparison of different dose response models for Listeria monocytogenes. 
Exp: exponential dose response model, BP: Beta-Poisson dose response model. Norm 
and Susc refer to the exposed population being either normal or susceptible to irlfections 
with this organism 
Escherichia coli 
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Haas et al (2000) developed a dose response relationship for E. coli 0157:H7 
based on an animal model for this organism from data produced by Pai et al (1986). 
This data was fitted to the beta-poisson dose response relationship, with validation based 
on outbreak data from the US. In this study the beta-poisson model goodness of fit 
(GOF) was compared with that of the exponential model. Haas et al (2000) state that 
although Shigella can be used in surrogate dose response modelling for E. coli 0157, 
the dose response relationship they present does not support the use of surrogacy 
between the two organisms. Intra-specific variability is inherent in all organisms, inter-
specific variability, however, is greater. Regardless, there have been attempts to model 
the dose response relationship for pathogenic E.coli with surrogate microorganisms, for 
example Shigella spp (Cassin et al, 1998). The dose response curves are reproduced in 
Fig 1.2. 
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Figure 1.2 Comparison of the Exponential and the Beta-Poisson dose response 
curve for E. coli 0157:H7. Redrawn from equations presented by Haas et al (2000). 
Cassin et al (1998) describe another dose response relationship for E. coli 
0157:H7. This model is based on human feeding trials for Shigella dysenteriae and 
Shigella flexneri. It assumes that the pathogenicity of shiga-toxin producing E. coli is 
similar to that of the Shigella species. The difference between their dose response 
relationship and that produced by Haas et al (2000), with the exception of surrogacy, lies 
in the model used. Cassin et al (1998) use a beta-binomial model as opposed to the 
beta-poisson model used by Haas et al (2000). Also Cassin et al (1998) describes a 
method for adjusting the model to cover portions of the population with varying 
susceptibility to illness from this pathogen. 
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An animal model was used to study the infectivity of E. coli 0157 in rats 
(Havelaar et al, 2000). The experimental design did not provide sufficient data to allow 
the development of a dose response relationship. Furthermore Havelaar et al (2000) did 
not highlight the problems associated with extrapolating an animal model-based dose 
response relationship to humans. Because of a lack of data in the published literature 
based on animal models for E.coli 0157 infection a description of the dose response 
relationship has not been included in this thesis. 
Powell et al (2000) described the development of two different sets of dose 
response models for E. coli. The first used Shigella dysenteriae as a surrogate for 
Shiga-toxin producing E. coli strains, the second used data from enteropathogenic E. 
coli (EPEC) strains. The data were derived from human feeding trials with 
enteropathogenic E. coli (EPEC) and S. dysenteriae Type 1 (Levine et al, 1973; Levine et 
al, 1978; Bieber et al, 1998). Three models for each data set were fitted: the exponential, 
the Beta-Poisson, and the Weibull-Gamma models. The fit parameters for those models 
are given in Table 1.13. Moreover, the aim of that paper was to describe an "envelope" 
dose response model for E.coli 0157:H7. An envelope model describes the highest 
and lowest dose response limits for infectious strains of E. coli, and then a mean dose 
response curve is fitted. The model chosen for the envelope was the beta-Poisson, with 
the upper and lower bounds defined by the surrogate pathogen (upper) and EPEC 
(lower) model. The median value for the envelope was again a beta-Poisson DR model, 
with epidemiological data from various sources, primarily concerned with ground beef in 
the USA. That model was the most complete, in terms of explanation of the process 
involved in generating the dose response curve, and provided a means of determining the 
variability in probability of infection between strains of E. coli. The dose response 
curves generated from the equations presented by Powell et al (2000) are presented (Fig 
1.3. overleaf). 
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Figure 1.3 Comparison of the dose response curves for E. coli 0157:.H7 
presented by Powell et al (2000). a, band c refer to datasets used to derive the dose 
response curve (see table 1.13). Exp= exponential, BP= beta-Poisson, WG =Weibull-
Gamma 
Haas et al (2000) show a greater degree of uncertainty in the low and high dose regions 
of the curve with the beta-Poisson model than does the beta-binomial mode used by 
Cassin et al (1998). The beta-binomial model used by Cassin et al (1998) gives a N50 of 
""3.2 x la3, whereas Haas et al's (2000) model gives the N50 at "'6.3 x 105• The reasons 
for this difference may arise from several sources; the data used, the method of 
parameter fitting for determining the relationship; the strain of the bacterium used, or the 
differences between the general form of the dose response curve described by the beta-
Poisson and beta-binomial models. 
Salmonella 
Teunis et al (1999) used the data collected from human feeding studies for 
Salmonella enterica serovar Meleagridis to develop a dose response relationship for this 
pathogen. The authors attempted to model both the dose response for infection and the 
dose response for illness resulting from infection. Teunis et al (1999) used the beta-
Poisson dose response relationship to model the probability of infection. Fitting of the 
dose response data resulted in the Beta-Poisson dose response model reducing to a 
simple exponential model. Summarised in Table 1.14 are the parameter values fitted to 
the dose response models. 
Whiting and Buchanan (1997), using an exponential dose response relationship, 
predicted that with an increase in prevalence of Salmonella Enteritidis in flocks of 
chickens the probability of illness increases. They used parameter values derived by 
Rose et al (1996). In Whiting and Buchanan (1997), the use of the dose response 
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Table 1.13 Summary of models for dose response relationship for 
E. coli 0157:H7 
Author Model Parameter Value 
Haas et al (2000) Exponential P1(D) 1- exp ~-D/k) 
K 1.6 x 10 
Beta-Poisson P1(D) 1 - [(l + D/N50(21'- - 1))"(- a)] 
a 0.49 
ED so 5.96 x 105 
Cassin et al (1998) Beta-binomial P1(D) 1 - (1 - P1(l))D 
Pi(l) Beta (a, j3) 
a 0.267 
j3 In j3 ,.., Normal (5.435, 2.47) 
Powell et al (2000) (a) 
Exponential r 2.052 x 10-4 
Beta-Poisson a 0.157 
j3 9.169 
ED so 742 
Weibull a 0.040 
gamma 
j3 239.327 
x 3.514 
(b) 
Exponential r 4.070 x 10-10 
Beta-Poisson a 0.221 
j3 3112348.268 
ED so 68494661 
Weibull a 1.944 
gamma 
j3 7409.340 
x 0.418 
(c) 
Beta-Poisson a 0.221 
j3 8722.480 
EDSO 16643 
.. P1(D) is the probability of Illness given a dose of D orgamsms 
Pi(I) is the probability of illness given a dose of I organism 
(a) denotes the model fit parameters for S. dysenteriae 
(b) denotes the fit parameters for EPEC 
(c) The median value for the envelope dose response model 
ED50 is the dose required to cause symptomatic illness in half the exposed 
population 
model is not purely to demonstrate the goodness of fit of the model but as part of a 
demonstration of the risk assessment process, and its ability to quantitatively describe 
the production of eggs and the associated contamination with Salmonella Enteritidis. 
The parameter value for the dose response model is shown (Table 1.14) and the curve 
generated is also presented (Fig 1.4). 
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Figure 1.4 Dose response curve for Salmonella Enteritidis in liquid eggs. 
(Reproduced from Whiting and Buchanan, 1997) 
Brown et al (1998) also produced a risk assessment for Salmonella in chickens. 
Those authors do not identify which serotype of Salmonella they chose for developing 
the risk assessment; neither do they give adequate explanation of the model. 
An animal model was used to study the infectivity of Salmonella Enteritidis in rats 
(Havelaar et al, 2000). The data presented in that paper indicate a high infectivity of the 
rats by Salmonella Enteritidis, however the authors did not describe a mathematical dose 
response relationship for this bacterium in rats. Lack of data precludes a description of 
the dose response relationship. 
Fazil et al (2000) compare three different dose response models, in a report for the 
PAO/WHO on the hazard characterisation, for Salmonella. The first details Fazil's 
(1996) beta-Poisson dose response model for infection for non-typhoid Salmonella on 
both nai"ve and exposed people, based on feeding study data. The second outlines the 
dose response model developed in the USDA/FDA (1998) Salmonella Enteritidis risk 
assessment model. Based on epidemiological data concerning Salmonella Enteritidis, 
the model proposed by the USDA/FDA study (1998) is a beta-Poisson model for 
illness. The third model outlined was presented in risk assessment paper developed by 
Health Canada (Paoli, 2000; Ross, 2000). For that risk assessment a re-parameterised 
Weibull model was used. The fit parameters for each of the models are shown in Table 
1.14. 
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Table 1.14. Parameter values for dose response models for Salmonella 
Author Model Parameter Value 
Whiting and Exponential r 0.00752 
Buchanan (1997) 
Teunis et al (1999) Beta-Poisson 0.89 
-
4.4 x 105 
-
Illness model P(illjinf) 1-(1 + _)-r 
1 
-
D 
-
1.0 x 10-16 
-
r 3.4 x 108 
Fazil et al (2000) Beta-Poisson 0.3136 
-
3008 
-
Beta-Poisson 0.4059 
-
(naYve) 
5308 
-
USDA-FSIS Beta-Poisson 0.2767 
-
(1998) (normal) 
-
Normal(21.159, 20) min: 0, 
max: 60 
Beta-Poisson 0.2767 
-
(susceptible) 
- -
Normal (2.116, 2) min: 0, 
max:6 
Health Canada Re-parameterised Normal(-1.22, 0.025) 
-
(see Fazil et al, Weibull 
2000) 
Concentration Lognormal(0.15, 0.1) 
Amount Pert(60, 130, 260) 
Consumed 
Attack Rate 6.6% 
Susceptible 8s 231 
bs 987 
Normal iln 749 
bn 5966 
P(illjinf) is the probability of becoming ill given that the person is infected. 
D is the dose of the ingested organism. 
Normal, NaYve, and Susceptible refer to the exposed population's immune status 
Campylobacter jejuni 
Medema et al (1996) used human feeding trial data to develop a dose response 
model for infection by Campylobacter jejuni. The exponential and beta-Poisson models 
were again used to produce dose response curves. The beta-Poisson dose response 
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model fitted the data 'adequately', whereas the exponential model provided a poorer fit 
to the data. Maximum likelihood estimates (MLE) of the fit parameters are presented in 
Table 1.15. The fit of the model parameters was found to be dependent on a range of 
host-microbe factors, including the presence or absence of flagellated strains of C. jejuni, 
however, no improvement in fit was found when the distinction between the flagellated 
and non-flagellated strains was made. 
Teunis et al (1999) also produced a dose response model for infection with C. 
jejuni based on human feeding trials. No comparison was made between the fit of 
different dose response models to the data. Table 1.15 presents a summary of the fitted 
parameters. The data set used by Teunis et al (1999) is the same as used by Medema et 
al (1996). Consequently the estimated model parameters are almost identical. Figure 
1.5 shows a comparison of the models produced by Teunis et al (1999) and Medema et 
al (1996). 
Holcomb et al (1999) compared six dose response models for infection with C. 
jejuni based on data sets selected from a literature search. The MLE of the fit 
parameters for each of the models is given in Table 1.15. 
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Figure 1.5 Comparison of the dose response curves for Campylobacter jejuni are 
based on the equations presented by Medema et al (1996) and Teunis et al (1999). The 
Beta-Poisson (BP) models are so similar they overlap in the figure above. 
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Table 1.15. Dose response parameters for Campylobacter jejuni 
I Author Model Parameter Value 
Medema et al Exponential r 3.52 x 10-6 
(1996) 
Beta-Poisson 0.145 
-
7.59 
-
Teunis et al (1999) Beta-Poisson 0.15 
-
7.9 
-
Holcomb et al Log-logistic 0.41 
-
(1999) 
Log-normal bo -0.83 
b1 0.29 
Simple exponential k 0.26 
Flexible exponential 
-
0.29 
Beta-Poisson 0.12 
-
2.46 
-
Weibull-gamma 0.05 
-
9.99 
Bacillus cereus 
Notermans et al (1997) describe the risk,assessment process for B. cereus m 
pasteurised milk. From various sources, they conclude, that the likely level of the 
organism required to induce symptomatic illness is >la5. This is a similar figure to that 
presented by Doyle et al (1997), who indicate that an infectious dose of this organism is 
between 105 -107 and 105 -108 will likely induce toxin production in the small intestine 
and in food, respectively. Those authors did not derive a dose response relationship for 
the organism. A lack of information regarding this organism's ability to induce illness, 
indications that not all strains of B. cereus are toxin producers, and differences between 
the level of organism required to cause either emetic and diarrhoeic illness are 
highlighted as difficulties in developing a suitable dose response relationship for this 
organism. 
1.8.3 Problems associated with microbial dose response models 
Foremost among the problems associated with the construction of dose response 
models for microbial pathogens is a lack of data. This prevents the accurate estimation 
of the response curve. For those curves that have been defined there are large 
uncertainty bounds, especially in the low dose region of the curve; but also in the high 
dose region, and there are no suitable mechanistic models currently available that 
describe this region (Haa1? et al, 2000; Teunis and Havelaar, 2000; WHO/PAO, 2002). 
Moreover, the source of data for constructing the dose response models is another 
I 
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potential problem. Several dose response models that have been developed are based on 
either surrogate organisms (Pai et al, 1986; Haas et al, 2000; Powell et al, 2000), from 
data collected from feeding trial studies (Cassin et al, 1998; Haas et al, 1999), or from 
animal feed trial studies (Holcomb et al, 1999). 
The use of surrogate organisms is problematic, as the models don't usually define 
the difference between the organisms for which the model is constructed for and the one 
used in the experiment; intra-specific variability is inherent in all organisms, however, 
inter-specific .variability is greater. Human feeding studies genera11y use a small healthy 
sample from a population and that sample is not representative of the population as a 
whole, thus reducing the validity of the constructed dose response model when applied 
to people not from the experimental group (Vose, 1998). Extrapolation from the dose 
response models developed from animal feeding studies also presents a problem as their 
applicability to humans is in question. 
1.8.4 Dose Response Assessment for Chemical Hazards 
This section considers chemical contaminants that may be present in dairy 
products and their associated health risks. Those considered included hormones, heavy 
metals, pesticides, herbicides and antibiotics. With the exception of heavy metals and 
hormones, the health effects from contact with these chemicals is relatively unknown. 
This is due to the difficulties of defining causal relationships when there is a long and 
variable time interval between 'exposure' and the possible onset of detectable health 
effects (Lammerding and Fazil, 2000). 
With the exception of large doses of any particular chemical hazard, there appears 
to be a threshold below which there is no observable adverse effect; this is known as the 
NOAEL. There are other measures of hazard used for chemical contaminants. These 
include the maximum residual limit (MRL), the limit of reporting (LOR), the effective 
maximum residual limit (EMRL), and the lowest observed adverse effect level (LOAEL). 
These measures of risk for chemicals are used to determine a tolerable daily intake 
(TDI) or allowable daily intake (ADI). That is, that average level of the substance that 
may be ingested regularly over the entire lifetime of the consumer without causing an 
effect (WHO, 1996). This value is determined by dividing either the NOAEL or the 
LOAEL by an uncertainty factor (UF). 
The UF is a means to incorporate in the TDI possible errors in extrapolation from 
animal feeding studies to the effects that may arise in humans. Extrapolation of models 
from animal bioassay data for chemicals to affects in humans may involve errors of 
several orders of magnitude (Smith, 1988). Typically the UF ranges from between 10 to 
1000. Values greater than 10 OOO are considered to indicate that the risk assessment 
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perlormed for that chemical would have produced TDI values of little meaning. 
Uncertainty factors are described in Table 1.16. 
Chemicals that are considered for a TDI include only those that are non-
carcinogenic. Carcinogenic chemicals are treated differently. It is generally considered 
that carcinogenic chemical compounds cause mutations in somatic cells as opposed to 
the gametes in humans. Thus, any amount of exposure to these genotoxic substances is 
considered a risk, as there is no threshold limit (WHO, 1996). There are, however, 
substances that may cause tumour development that are not genotoxic. These may have 
a threshold limit, but the mechanisms surrounding cancer development from these 
substances is not well understood. 
Table 1.16 Uncertainty factors for determining tolerable daily intake for 
chemicals (Reproduced from WHO, 1996) 
Source of uncertainty Factor 
Interspecies variation (animals to humans) 1-10 
Intraspecies variation (individual variations) 1-10 
Adequacy of studies or database 1-10 
Nature and severity of effect 1-10 
Again the typical method for determining the toxicity, or carcinogenicity of the 
compounds under consideration involves a combination of animal tests and 
epidemiological data gathered from people exposed to the chemical on a regular basis. 
Several different classes of carcinogenic compounds are distinguished, from those that 
are known human carcinogens, to those that are probably not carcinogenic (Table 1.17). 
To most consumers the idea of consuming any amount of carcinogenic substance 
in food is unacceptable. For this reason the government of the United States of America 
changed the laws regarding food production by introducing the 'Delaney clause'. This 
was intended to prevent carcinogenic s,ubstances from entering the food supply. 
However, since the clause was added to the legislation there has been much controversy 
and public debate over which substances can and cannot cause cancer. Moreover the 
question arises, do we have sufficient information available to define unequivocally 
which substances will cause cancer and at what dose (Merrill, 1997)? 
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Table 1.17 Classes of carcinogenic compounds (reproduced from WHO, 1996) 
Group 1. The agent (mixture) is carcinogenic to humans. 
The exposure circumstance entails exposures that are carcinogenic to humans. 
This category is used when there is sufficient evidence of carcinogenicity in humans. Exceptionally, an 
agent (mixture) may be placed in this category when evidence in humans is less than sufficient but there 
is sufficient evidence of carcinogenicity in experimental animals and strong evidence in exposed humans 
that the agent (mixture) acts through a relevant mechanism of carcinogenicity. 
Group 2 
This category includes agents, mixtures, and exposure circumstances for which, at one extreme, the 
degree of evidence of carcinogenicity in humans is almost sufficient, as well as those for which, at the 
other extreme, there are no human data but for which there is evidence of carcinogenicity in 
experimental animals. Agents, mixtures, and exposure circumstances are assigned to either group 2A 
(probably carcinogenic to humans) or group 2B (possibly carcinogenic to humans) on the basis of 
epidemiological and experimental evidence of carcinogenicity and other relevant data. 
Group 2A. The agent (mixture) is probably carcinogenic to humans. 
The exposure circumstance entails exposures that are probably carcinogenic to humans. 
This category is used when there is limited evidence of carcinogenicity in humans and sufficient 
evidence of carcinogenicity in experimental animals. In some cases, an agent (mixture) may be 
classified in this category when there is inadequate evidence of carcinogenicity in humans and sufficient 
evidence of carcinogenicity in experimental animals and strong evidence that the carcinogenesis is 
mediated by a mechanism that also operates in humans. Exceptionally, an agent, mixture, or exposure 
circumstance may be classified in this category solely on the basis of limited evidence of 
carcinogenicity in humans. 
Group 2B. The agent (mixture) is possibly carcinogenic to humans. 
The exposure circumstance entails exposures that are possibly carcinogenic to humans. 
This category is used for agents, mixtures, and exposure circumstances for which there is limited 
evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in 
experimental animals. It may also be used when there is inadequate evidence of carcinogenicity in 
humans but there is sufficient evidence of carcinogenicity in experimental animals. In some instances, 
an agent, mixture, or exposure circumstance for which there is inadequate evidence of carcinogenicity in 
humans but limited evidence of carcinogenicity in experimental animals together with supporting 
evidence from other relevant data may be placed in this group. 
Group 3. The agent (mixture or exposure circumstance) is not classifiable as to its carcinogenicity to 
humans. 
This category is used most commonly for agents, mixtures, and exposure circumstances for which the 
evidence of carcinogenicity is inadequate in humans and inadequate or limited in experimental animals. 
Exceptionally, agents (mixtures) for which the evidence of carcinogenicity in inadequate in humans but 
sufficient in experimental animals may be placed in this category when there is strong evidence that the 
mechanism of carcinogenicity in experimental animals does not operate in humans. 
Agents, mixtures, and exposure circumstances that do not fall into any other group are also placed in 
this category. 
Group 4. The agent (mixture) is probably not carcinogenic to humans. 
This category is used for agents or mixtures for which there is evidence suggesting lack of 
carcinogenicity in humans and in experimental animals. In some instances, agents or mixtures for 
which there is inadequate evidence of carcinogenicity in humans but evidence suggesting lack of 
carcinogenicity in experimental animals, consistently and strongly supported by a broad range of other 
relevant data, may be classified in this group. 
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These considerations aside, what follows is a list of potential chemical 
contaminants in dairy products. Some may be of more importance depending on the 
conditions at the dairy farm, whereas others are included for completeness. Where 
possible MRLs for each chemical is given. 
Hormones 
Hormones are used within the cattle and dairy industry to increase growth rate, 
feed conversion and milk production, and can be either endogenous or synthetic 
(Waltner-Toews and McEwen, 1994d). Among the most widely known is Bovine 
somatotropin (BST), used in cows for increasing milk production. It is not available in 
Australia but widely used in the US. For hormones that may, but not necessarily, be 
used the ADI and withdrawal times have not been established for testosterone, 
progesterone, oestrogen and somatotropin, but these are generally not used in Australia. 
These hormones are used as feed supplements. The reason for not establishing the ADI 
is based on the premise that these are naturally occurring compounds, tissue residue 
levels are within the normal range, and hence health problems are minimal. The main 
risk from these hormones is from humans ingesting implants not removed prior to or 
during the carcass dressing process (Waltner-Toews and McEwen, 1994d). 
Xenobiotic, manmade, hormones used worldwide include trenbolony acetate 
(TBA), melangestrol acetate (MGA), zeranol and the stilbenes. Trenbolone, is a 
synthetic steroid compound that is not considered genotoxic. The MRL in edible tissue 
is 0.7µg/kg for ~-hydroxytrenbolone and 7.0 µg/kg for a-hydroxytrenbolone, it's two 
main derivatives (Waltner-Toews and McEwen, 1994e). The ADI is established from 
hormonal studies in pigs, and set at 0- 0.02 µg/kg/day. 
MGA is an orally active progestrogen, used in heifers as a feed additive. The 
MRL has been set at 25 µglkg (25ppb) in edible tissue. 
Somatotropin (ST) is also known as "growth hormone" and has been subject to 
much debate, although it is ~ot currently used in Australia. Known since the 1920s, it 
can increase milk production and has been used (or licensing sought) with dairy cows. 
ST is not anabolically active in humans when given orally. BST (bovine somatotropin) 
occurs naturally in milk and with care treated and untreated animals have the same 
residual levels present in milk. However insulin-like growth factor is present in the meat 
of treated cattle at twice the normal level. No evidence exists that these increased IGF-1 
levels pose a health risk. 
Correct usage of xenobiotic substances should not leave a residue with an affect in 
humans from the consumption of contaminated tissue. However, incorrect use of the 
hormonal substances may lead to undesirably high residue levels that may have an 
adverse health affect in humans (Waltner-Toews and McEwen, 1994d). 
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Pesticides/Herbicides 
Food was estimated to comprise up to 90% of the exposure source of insecticides 
for the general population of Ontario, with milk, eggs and meat accounting for >40% of 
food related exposure, with fish a further 25%. (Waltner-Toews and McEwen, 1994b). 
Hence agricultural insecticides are of particular concern for public health. These 
include: Organochlorines (including DDT and its relatives, hexachlorohexane 
derivatives, cyclodienes and polychloroterpenes), organophosphates and carbamates 
(Waltner-Toews and McEwen, 1994b). Cattle may be contaminated with various 
organochlorines including dieldrin, heptachlor, hexochlorobenzene (HCB) and 
chlordane as a result of pesticide use during crop production,. pasture production, 
horticulture, and the treatment of buildings and fittings (Waltner-Toews and McEwen, 
1994b). These agricultural chemicals bioaccumulate in the body fat of animals and can 
be conveniently detected by assaying the milk fat chemicals are persistently found in the 
milk fat. The ability of these chemicals to bioaccumulate in animals and persist. in the 
environment makes them a long-term residue hazard in all animal production systems. 
Consequently they have largely been banned from agricultural use in Australia and they 
cannot legally be applied to animals. 
Fenthion, a cholinesterase inhibitor used as a pesticide, may also be present. The 
oxidative metabolites are more potent than the parent compound. Persistence of fenthion 
in milk of treated cattle rises to a maximum after "'8hr and falls to below 0.05 mg/kg 
within 24 hours, which at the time of writing, was the maximum allowable limit for this 
pesticide in raw milk (O'Keeffe et al, 1983). 
Antibiotics and antiparasitic drugs 
Problems associated with antibacterial residues in food include - direct toxicity, 
allergic reactions, development of resistant bacteria, and interference with starter cultures 
for fermented foods (Waltner-Toews and McEwen, 1994d). A large number of 
antibacterial and anti parasitic drugs are available for use with animals, however, not all 
have been reported as residues in foods. Moreover, they are found in very small 
concentrations in foods, generally far below the level required to cause an adverse 
reaction in humans. A list of the antibacterial and antiparasitc drugs that have been 
found in foods of animal origin is shown in Table 1.18. These are not specific to milk 
or dairy products. 
In Australia antibacterial residues in milk have decreased in prevalence and amount 
in the last 30 years, despite increases in testing sensitivity (ANRSP, 1999). Australia 
reported as low as 0.07% failure to comply with regulations regarding the use of 
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antimicrobials and their presence in dairy farm vats, tankers and milk factory silos 
(ANRSP, 1999). 
Table 1.18 Antibacterial and antiparasitic drugs found in foods from animal 
origin (from Waltner-Toews and Mc Ewen, 1994e) 
Tetracycline Relatively non toxic to humans and animals 
Effects of At therapeutic doses - peripheral blood changes, 
discolouration of the bones and teeth, and allergic reactions in 
humans 
Low doses (20mg oxytetracycline/person/day)-may affect 
the anaerobic faecal microflora in humans 
ADI, MRLetc ADI of 0-0.003 mg/kg body wt (humans) 
13-lactam antibiotics Relatively non-toxic at therapeutic doses 
Recent additions to this family of antibiotics have higher 
toxicity - imipenum and some cephalosporins 
Effects of Responsible for the majority of allergic reactions to antibiotics. 
Rate of adverse effect 4-15/100 OOO courses of treatment, 
1-5/100 OOO penicillin courses 
Those with reactions may have high sensitivity. Overall 
sensitivity is between 3 and 10% of the population 
ADI,MRLetc Doses below 0.01 µg /ml of penicillin are not important 
allergenically 
Sulphonamides Toxic 
Effects of Effect on thyroid function, hypersensitivity reactions (skin 
rashes), rare cases of agranulocytosis and aplastic anaemia 
ADI,MRLetc ADI 0 - 0.004 mg/kg body weight/day 
A rough estimate due to insufficient data 
Aminoglycosides and All are toxic, this family includes - streptomycin, 
others dihydrostreptomycin, gentamicin and neomycin. 
Nitrofurans - furazolidone and nitrofurantoin 
Effects of Urinary, vestibular and auditory d<;llllage, Allergic reaction to 
therapeutic doses 
Nitrofurans are toxic and have mutagenic and carcinogenic 
potential 
ADI,MRLetc Neomycin 0.5, Streptomycin 0.2 (mg/kg) 
Antiparasitic drugs closantel, ivermectin, levamisole, albendazole, dimetridazole, 
ipronidazole, ronidazole and carbadox 
Effects of Some evidence for carbadox and some of its metabolites being 
carcinogenic and genotoxic Dimetridazole and ipronidazole 
increase mammary tumours in rats. Levamisole associated 
with haematological abnormalities in humans 
With the hazards identified, their effects characterised and where possible a dose 
response assessment performed, the likely exposure to those hazards and the magnitude 
of that exposure is required before an estimate of the risk from each hazard can be 
elucidated. The following section describes the process of exposure assessment. 
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1.9 Exposure Assessment 
Exposure assessment is the characterisation of the likelihood of encountering a 
particular hazard in a food product and the magnitude of that encounter (Lammerding, 
1997). The process of assessing the degree to which humans are exposed to a particular 
hazard is potentially complex. The steps involved vary according to the terms of 
reference of the risk assessment, the extent to which the work is quantitative, and the 
biological and physical processes that affect the concentration of hazard in the process 
being examined. The amount of that product acting as the vehicle that is consumed 
during a particular timescale needs to be known, i.e. the consumption pattern of the 
identified vehicle. Consumption patterns are the frequency of consumption of a product 
or group of products and >the likely range of the amount consumed. The age and gender 
of the consumer can also be of importance because consumption and immune status 
varies according to age and gender. Finally an estimate of the likely magnitude of the 
exposure is required. This is based on the estimation of the likely contamination events 
and the magnitude of those events in the context of where they occur during the 
production of the food. A profile of the health, disease, and immune status, of the 
consuming population should also be known. 
The consumption pattern data and the health profile will not be discussed here, the 
reader is referred to the Materials and Methods, Results and Conclusion for the former 
and Appendix B for the latter. 
For the majority of food processing operations a chemical hazard will neither be 
destroyed nor generated within the food. Microbial hazards have the potential to either 
grow or die between the time that the food is harvested to the time that it is consumed 
(Ross, 1999; Whiting and Buchanan, 1997); hence the necessity of trying to establish 
the steps and processes involved in the production of food between the farm and the 
consumer, or in the farm-to-fork continuum. Where possible it is better to include 
growth and inactivation steps within the exposure assessment rather than making 
assumptions that preclude possible growth or inactivation of microbiological pathogens. 
However, in some situations there might not be enough information about a particular 
farm-to-fork pathway to establish the likely growth and inactivation. In these situations 
it may be more useful to identify the steps involved and use a more qualitative 
description of the process until such time as a quantitative description is possible 
(Lammerding and Fazil, 2000). 
The sources of hazards, either intrinsic to the process of from an external addition, 
need to be identified, together with the likely amount or concentration of the hazard 
entering from that source. This is what exposure assessment adds to the risk 
assessment process (Jaykus, 1996; Lammerding, 1997). There may be a huge array of 
potential sources' for any particular hazard. What is required is some mediation between 
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the risk assessor and the risk manager to refine the scope of the exposure assessment 
regarding the inclusion of these sources (Lammerding, 1997). 
1.10 Risk Characterization 
Risk characterisation is the final step in the formal part of a risk assessment. It is 
the synthesis of the exposure assessment and the dose response assessment to arrive at 
an estimate of the risk, i.e. the likelihood that a population will suffer an adverse effect, 
and its severity, associated with a particular hazard (Buchanan et al, 2000). Moreover, 
risk characterisation is a statement about the assessor's confidence in the analysis. The 
characterisation of risk may be either quantitative or qualitative (Jaykus, 1996, 
Lammerding, 1997). Also the nature of the risk characterisation should reflect the 
uncertainties within the assessment, data gaps, potential problems with the assessment 
process, and the affect that critical assumptions in the exposure and dose response 
assessments have on the interpretation of the results (Buchanan et al, 2000). 
The form that the risk characterisation takes, qualitative or quantitative, is largely 
dependent on the way that the other steps in the risk assessment were performed. For a 
quantitative risk assessment, the risk characterisation will take the form of a numerical 
estimate (Lammerding, 1997). The arrival at a numerical estimate derives from either the 
simulation of all possible results, through the sampling from distribution functions 
describing some or all factors in the model, via Monte Carlo analysis (Buchanan et al, 
2000) or by using a deterministic approach. A stochastic approach is considered 
preferable to a deterministic one because it is possible to incorporate both uncertainty 
and variability directly. The main problem with using this type of analysis is the 
interpretation and presentation of the results. Even with a numerical estimate of risk, it 
may be more useful to offer a qualitative description of that risk rather than give a mean 
value with confidence intervals. This method will, however, reduce the value of the 
overall assessment, and with proper communication and interpretation of the results it is 
more beneficial to use a fully quantitative estimate (Lammerding, 1997). 
1.11 Project Objective 
This project is part of industry-funded research to produce a food safety risk 
assessment model for the Australian dairy industry. The objective of this project was to 
develop a model for assessing the likelihood and severity of adverse health outcomes in 
people who consume Australian dairy products. The purpose of the model was both to 
estimate the risk of illness from the consumption of dairy products, and to identify 
research needs for food safety within the Australian dairy industry. 
To gain a better understanding of the Australian dairy industry, discussions were 
held with representatives of dairy manufacturing companies and other dairy industry 
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stakeholders in the project and visits were made to dairy farms and processing factories. 
Concurrently, SafeFood NSW was conducting a risk assessment for the NSW dairy 
industry. It was beneficial to both parties to collaborate and pool resources to achieve a 
common objective. It was hoped that upon completion of the project the model would be 
useful both as a research tool in the broader Australian dairy industry and for meeting 
the state specific requirements of the dairy regulator in NSW. 
The overall aim of the project was to provide a food safety risk assessment 
framework for the Australian dairy industry, through the collection of specific 
information regarding that industry and its collation and organisation into a structured 
and flexible spreadsheet model. The model was primarily concerned with the estimation 
of the likely hazard concentrations in liquid milk, whereas the remainder of the overall 
project was concerned with the description of these hazards in other dairy products, their 
potential health effects in humans and a description of the health status of the consuming 
population in Australia. 
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2. Materials and Methods 
2.0 Characterisation of the dairy industry 
A range of characteristics of the Australian dairy industry can conceivably affect 
the risk of human illness arising from the consumption of dairy products. Thus a 
strategy was adopted where the characteristics of the NSW dairy industry could be 
assessed and used as a basis for a model that could be scaled (extrapolated) to 
encompass the entire industry in Australia. The NSW dairy industry was regarded as 
suitable because it encompasses a wide range of dairy production systems due to the 
variety of climatic and geographic regions in that state in which milk is produced and 
marketed. Information was gathered from a survey sent to 70 dairy processing factories 
in NSW. The survey requested data from each of the factories regarding; the volumes 
of finished product per year; the volume of raw materials used annually; the number of 
farms supplying the factory; the number of cows on those farms, including the 
proportion of those "in milk"; the types of microbiological tests performed on the 
product and around the factory; results of those tests, including frequency of failures, the 
products implicated and the hazard concerned; the pasteurisation time and temperature 
conditions and the number of pasteurisers used at the factory (both high temperature 
short time and batch pasteurisers); degree of compliance with mandated farm pick-up 
temperatures (i.e. 4°C regulation) and the maximum temperature of milk collected from 
the farm. The questionnaire is presented in Appendix A. 
2.1 Hazard Identification 
There are more than 70 potential microbial contaminants of milk, of these there are 
several that are clearly pathogenic and others that may be potentially pathogenic (van 
Gerwen, 2000). It is impractical to consider all within a single risk assessment. 
Therefore (as noted in section 1.7) a meeting between the risk assessment team and 
stakeholders in the project was held to discuss the pathogens of most current concern to 
the dairy industry. The stakeholders were representatives of major dairy product 
manufacturers in Australia, the Dairy Research and Development Corporation (DRDC), 
and controlling authorities which included quality control officers, project managers, 
production managers and research officers. The pathogens of most concern to the 
industry were Identified, prioritised, and those associated with specific product groups 
were listed as the highest priority. At the same time stakeholders discussed chemical 
anc;I physical hazards of greatest priority. 
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2.2 Hazard Characterisation 
Each of the potential hazards identified was considered in detail, identifying modes 
of transmission, aetiology and virulence. This information was presented in the literature 
review under hazard identification (1.7) and hazard characterisation (1.8). 
2.2.1 Growth kinetics of pathogenic microorganisms 
The growth kinetics of several bacterial pathogens included in the risk assessment, 
i.e. Escherichia coli, Listeria monocytogenes, Staphylococcus aureus, Bacillus spp. and 
Salmonella spp were collated. For these pathogens a published mathematical growth 
model existed (Gibson et al, 1988; Buchanan and Phillips, 1990; Ross and McMeekin, 
1991; Benedict et al, 1993; Buchanan et al, 1993a; Buchanan et al, 1993b; Tienungoon, 
1998; Ross et al, in press). The models used are temperature based with growth 
conditions that of liquid milk (pH 6.5, aw 0.995). 
The growth rate of the microbiological hazards modelled, as predicted from the 
USDA's Pathogen Modelling Program and University of Tasmania's Microbiology 
group, are presented in table 2.2.1.1. Predictions were generated for a limited range of 
temperatures. The mean estimated growth rate for each microorganism from the models, 
without confidence intervals, was used in the model. 
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Table 2.2.1.1 Growth rate estimates (generations/hour) for microbiological 
hazards from Pathogen Modelling Program (a) and University of Tasmania 
microbiology group (b) 
'a) 
E.coli Salmonella L. Y. C. jejuni B. cereus S. aureus Temo monocytogenes enterocolitica 
0 - - - - - -
l - - - - - -
2 - - - - - -
3 - - - - - -
4 - - 0.084 - -
-
5 0.000 - 0.102 0.115 0.067 -
6 0.000 - 0.123 0.137 0.081 -
7 0.000 - 0.147 0.164 0.096 -
8 0.000 - 0.175 0.192 0.115 -
9 0.130 - 0.208 0.227 0.137 -
10 0.159 0.110 0.250 0.263 0.161 0.074 
11 0.192 0.145 0.294 0.313 0.192 0.093 
12 0.227 0.189 0.345 0.357 0.222 0.116 
13 0.270 0.244 0.400 0.417 0.263 0.143 
14 0.323 0.313 0.455 0.476 0.303 0.179 
15 0.385 0.385 0.526 0.526 0.357 0.217 
16 0.435 0.476 0.588 0.588 0.417 0.263 
17 0.526 0.588 0.714 0.667 0.476 0.313 
18 0.588 0.714 0.769 0.714 0.526 0.385 
19 0.667 0.833 0.909 0.833 0.625 0.455 
20 0.769 I.OOO I.OOO 0.909 0.714 0.526 
21 0.909 1.111 1.111 I.OOO 0.769 0.625 
22 I.OOO 1.250 1.250 1.111 0.909 0.714 
23 1.111 1.429 1.429 1.111 I.OOO 0.833 
24 1.250 1.667 1.429 1.250 1.111 0.909 
25 1.429 1.667 1.667 1.250 1.250 1.111 
26 1.429 2.000 1.667 1.429 1.429 1.250 
27 1.667 2.000 2.000 1.429 1.667 1.429 
28 1.667 2.000 2.000 1.429 1.667 1.429 
29 2.000 2.500 2.000 1.429 2.000 1.667 
30 2.000 2.500 2.500 1.667 2.000 1.667 
31 2.000 - 2.500 1.667 2.500 2.000 
32 2.500 - 2.500 1.667 2.500 2.000 
33 2.500 - 2.500 1.667 2.500 2.000 
34 2.500 - 2.500 1.667 2.500 2.500 
35 2.500 - 3.333 1.667 3.333 2.500 
36 2.500 - 3.333 1.667 3.333 2.500 
37 2.500 - 3.333 1.667 3.333 2.500 
38 3.333 - - 1.667 3.333 2.500 
39 3.333 - - 1.429 3.333 2.500 
- md1cates that temperature was outside the range of the model's pred1ct10n 
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(b) 
E. coli Salmonella* L . Y. C. jejunt B. cereus S. aureus Temp monocytogenes enterocolitica 
0 0.000 0.000 0.000 0.000 0.000 
1 0.000 0.000 0.000 0.000 0.000 
2 0.000 0.000 0.003 0.000 0.000 
3 0.000 0.000 0.010 0.000 0.000 
4 0.000 0.000 0.021 0.000 0.000 
5 0.000 0.000 0.036 0.000 0.000 
6 0.000 0.000 0.056 0.000 0.000 
7 0.000 0.000 0.080 0.000 0.000 
8 0.049 0.000 0.108 0.000 0.000 
9 0.077 0.080 0.141 0.000 0.000 
10 0.112 0.115 0.178 0.000 0.000 
11 0.154 0.156 0.219 0.000 0.000 
12 0.202 0.204 0.265 0.000 0.000 
13 0.256 0.259 0.314 0.000 0.156 
14 0.317 0.3 19 0.368 0.000 0.203 
15 0.385 0.386 0.427 0.000 0.257 
16 0.459 0.460 0.489 0.209 0.318 
17 0.539 0.539 0.556 0.258 0.384 
18 0.626 0.626 0.627 0.312 0.457 
-19 0.720 0.718 0.703 0.372 0.537 ...J 
20 0.820 0.817 0.782 0.436 0.622 en 
• 21 0.926 0.922 0.866 0.506 0.715 
22 1.039 1.034 0.954 0.580 0.813 
23 1.158 1.152 l.047 0.660 0.918 
24 1.284 1.276 1.144 0.746 1.029 
25 1.415 1.407 1.245 0.836 1.146 
26 1.553 1.544 1.350 0.931 1.270 
27 1.696 1.687 1.459 1.032 1.400 
28 1.845 1.836 1.572 1.138 1.537 
29 1.998 l.991 1.688 1.249 1.679 
30 2.157 2.152 1.807 1.365 1.827 
31 2.319 2.3 17 1.927 1.486 l.981 
32 2.483 2.488 2.046 1.612 2.141 
33 2.649 2.661 2.159 1.744 2.304 
34 2.813 2.837 2.259 l.880 2.470 
35 2.974 3.013 2.333 2.022 2.635 
36 3.128 3.185 2.355 2. 168 2.795 
37 3.270 3.349 2.289 2.319 2.941 
38 3.392 3.497 2.072 2.475 3.059 
39 3.488 3.618 1.629 2.634 3.123 
*Denotes that the model estimates are derived from a generic exponential growth model equation 
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2.2.2 Thermal death kinetics of pathogenic microorganisms 
A literature search was conducted to find a suitable method to model the effect of 
pasteurisation on bacterial pathogens that may be present in raw milk. Papers that 
described either mathematically, or through laboratory experiments, the thermal death 
kinetics of several bacterial pathogens were considered. The pathogens included were 
Escherichia coli, Listeria monocytogenes, Staphylococcus aureus, Campylobacter spp, 
Bacillus spp. and Salmonella spp. For the remaining pathogens (section 1.3), there was 
insufficient published information to construct thermal death models. 
Papers that described the D or z value were of particular importance. The D-value 
is the time, in seconds, taken to reduce a population of bacterial cells by one log cycle at 
a given temperature, also known as the decimal reduction time (Mackey and Bratchell, 
1989; Murphy et al, 2002). This assumes that the temperature is beyond the maximum 
temperature for growth of that organism. The z-value is the temperature increase 
required to reduce the D-time tenfold (Murphy et al, 2002). Where possible data 
concerning dairy products, and in particular liquid milk, were used to determine the fit 
parameters of the log-linear inactivation curve. Where no specific data for milk existed a 
composite curve consisting of pooled data for that organism is used as a surrogate 
(Appendix C presents the entire dataset from the published thermal inactivation times 
and temperatures and references). 
2.3 Exposure Assessment 
Assessment of the likely intake of chemical, microbiological or physical hazards 
through the consumption of milk and milk products and the consequences of those 
exposures was performed in two parts. Firstly, by estimating the consumption of dairy 
products, both frequency and serving size, by Australians and secondly by producing a 
health profile of the Australian population (Appendix B). These two pieces of 
information make it possible to predict the number of pathogens being ingested, given 
that ~e concentration of cells or toxins in the product is known. 
2.3.1 Consumption Patterns of Dairy Products in Australia 
The consumption of dairy products by age and state were examined. These 
consumption patterns detailed the amount and frequency of consumption of particular 
dairy product group. They were obtained through discussions with industry 
representatives and the collection and collation of information found in the Australian 
Bureau of Statistics National Nutrition Survey (ABS, 1997) and from the annual and 
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monthly statistics publjshed by the Australian Dairy Corporation (ADC, 2000) and the 
Australian Dairy Industry Council (ADIC, '2000). 
2.4 Risk Characterisation 
To characterise the distribution of risk to humans of consuming in milk the range 
of hazards considered that may be present, the model was run using Monte Carlo 
simulation (see section 1.8). Each time the model was set to run for 30 OOO iterations. 
For each iteration the model selects a value from each of the distribution functions within 
the model and calculates the final output based on .calculations between each of these 
sampled values. The results from each iteration are stored and at the end of the 
simulation presented in a table that lists each of the outputs from the model, the 
individual results for each iteration (if requested) together with a summary based on 
descriptive statistics (mean, standard deviation, maximum, minimum, skewness, kurtosis, 
etc). 
2.5 Model Development 
The information gathered in the previous steps (section 2.2 and 2.3) was used to 
develop the risk assessment model. Several pathogens were modelled, and the flexibility 
built into the model allows for the risk from one or several different pathogens to be 
modelled during any single simulation. The objective of the model was to estimate the 
likely contamination of raw milk at the farm level with hazards, both microbiological and 
chemical, and to estimate the likelihood and frequency of exposure to those hazards in 
the finished dairy product. The model is a synthesis of the hazard identification and 
characterisation, exposure assessment and characterisation of the dairy industry. This 
section describes the development of the simulation model up to pasteurisation. 
Sources of Hazards at the Farm Level 
Fault tree analysis (AS/NZS, 1995) revealed that the model would be best 
configured with the individual cow assumed to be the primary source for milk 
contamination. That is, each cow is the source of milk for the model/industry, and 
contamination of the milk from that cow occurs by exposure of the individual cow to 
feed, pasture and environment etc. There are other sources of contamination conceivable 
prior to the cow, and from sources other than the cow, but a workable model can be best 
considered by considering each cow as being the initial source for all milk contamination 
(Fig 2.1). Other sources of contamination in raw milk are listed in Table 2.1. 
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Overview 
A description of the model follows, detailing the input variables and distributions, 
the mathematical operations used and the outputs of the model. For clarity each stage in 
the model is described separately, and where possible the values used for the distribution 
parameters is omitted, to allow the logic and sequential steps of the model to become 
apparent to the reader. The input values for the distribution parameters are detailed in 
the Chapter 3. The logical steps and assumptions included in the description of the 
model are described in detail so that it is possible to reconstruct the model accurately, 
thus fulfilling one of the principles of risk assessment: transparency. A general 
overview of the model is shown (Fig 2.2) indicating the different stages, or modules, 
within the overall risk assessment model. There are three modules that have not been 
fully developed, but are included for completeness and to give an indication where 
further research is needed. For each model parameter that is used in the calculation of 
any other value, the parameter's identifier is given in italics. The model was developed 
on a Microsoft Windows based computer running Excel 2000 (Microsoft Corporation) 
and @Risk v4.05 and later @Risk v4.5 (Palisade Corporation). 
Feed 
~ Human / Processing 
Pasture 
-----~ • / 
Other Environmental 
Fig 2.1 Contamination sources centre at the individual cow 
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Table 2.1 Sources of milk contamination (Vamam and Evans, 1991) 
Bovine faeces Defecation into milk 
Contamination of udder via bedding etc 
Contamination of milker's hands etc 
Contamination of milking equipment after dropp~ng on floor 
Oral antibiotics passing through to faeces contaminating milk 
Udder infection Undetected sub-clinical mastitis or asymptomatic infection 
Use of mastitic milk 
Antibiotics passed through udder into milk 
Milking Personnel Direct transfer from unwell person to milk 
Indirect transfer from unwell person via contamination of 
milking equipment 
Environmental Udder contamination from stream or pond water, infected 
sources pasture etc. 
Chemical contaminants on pasture or other feed passing 
though to milk 
1 Farm Level Module 
Mille Production Microbial 
Contamination Growth 
Tanker Level Module 
Milk Collection Microbial ,......_,...._ 
Growth· 
3 Factory Level Module 
M"lk C ll . Microbial 1 o ect1on Growth 
4 p . . 
asteur1sat10n 
5 
Post Pasteurisation 
Contamination 
Storage and Distrubution 
Consumption and 
Risk Estimate 
Fig 2.2 Overview of dairy risk assessment model structure. Modules 1-4 are 
complete; module 5 comprises the remaining three aspects of the risk assessment (These 
will be conducted subsequently as apart of the overall project described in section 1.11). 
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2.5.1 Farm Level Module 
Objective: 
This module predicts the volume of raw milk produced from herds of different 
sizes each day. It also estimates the bacterial and chemical contamination of raw milk 
from each herd prior to collection by the milk tanker. In the case of microbial hazards it 
estimates the potential growth of these organisms present during storage in the farm 
milk vat. 
. Inputs: 
Variable Description Identifier 
Probability that the farm is "Large" in size P(LF) 
Probability that the farm is "medium" in size P(MF) 
Herd Size HS 
Probability that the herd is contaminated with hazard P(HC) 
P(ChemHaz) 
Number of cows contaminated CHs 
Number of cows within a herd that are not contaminated UCHs 
Probability that the udder is contaminated given that the herd is P(UCIHC) 
contaminated with the hazard 
The number of cells contaminating milk produced from each CHb 
contaminated cow 
The amount of chemical contamination from each contaminated CCL 
cow (grams) 
Mean daily milk production per cow (L) µd 
Variance of daily milk production (L) a2 d 
Volume of milk produced by a herd (L) HM 
The contamination level on each udder UCL 
Temperature of the farm milk vat (°C) TFV 
Time milk spends in the farm milk vat (hours) tFV 
Generation time of the pathogen (hours) GT 
Number of bacteria present in the milk vat N0 
Assumptions made in this part of the model include that: 
• There is no seasonal variation in milk production 
• The hazard status of the cows does not affect the volume of milk produced 
from these animals. A contaminated cow produces the same volume of 
milk as a healthy one. 
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• 
• 
• 
• 
• 
• 
• 
• 
• 
The mean volume of milk produced per cow per day is the same regardless 
of the breed of cow. 
The size of the herd does not affect the milk production of individual cows . 
Milk production and hazard status of each cow is allocated independently 
of the other cows in the same herd (i.e. no clustering within herd based on 
features such as age or position in the milking queue is modelled) 
That milk in the vat prior to collection is at a constant temperature . 
Hazards present in the raw milk are distributed evenly throughout the 
entire volume of milk. 
Udder contamination is transferred into milk at the time of milking . 
There is no lag phase for pathogens present in the farm milk vat 
All bacterial cells of a given species grow at the same rate, i.e. the 
population of cells is in the same growth phase at all times. 
The number of cells contaminating the udders of infected cattle is a 
constant value. 
Size of Farm 
Three farm sizes or classes have been modelled, 'small', 'medium' and 'large' to 
reflect the various sizes of farms present. This distinction is based only on the size of 
the herds that they contain. A 'large farm' is defined as a farm that has a mean herd size 
of 390 (a = 75), and is modelled by a normal probability distribution. Similarly for 
medium and small farms, 174 (a= 30), and 70 (a= 15) cows respectively were used. 
Fig 2.3 shows the range of total herd sizes in each farm size group, as per the survey 
data (section 2.0). For each farm being modelled, the size of the farm is determined 
using a Bernoulli trial (Vose, 2000) with the probability that the farm size is large given 
by P(LF). 
35 65 90 125 175 225 275 325 375 450 550 
Median Herd Size 
Fig 2.3 Total cows in each farm size (NSW Survey data) 
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Farm Size (0,1),.., binomial (1, P(LF)) 
If the return value, farm size, equals 1, then the farm is Large, if the return value 
equals 0, then the farm is not large. 
If the farm is not large then there is a chance that it will be medium in size. Using 
the a similar process as with the above, a Binomial distribution with sample size 1, the 
probability that the farm is medium sized P(MF) is used. 
Farm size (0,1),.., binomial (1, P(MF)) 
If the farm is neither large nor medium in size, then it is assumed to be small, the 
only remaining farm size class. 
Once the "population" of farms has been generated, the size of the herd on each 
farm is determined using a normal distribution by referring to the specified mean and 
standard deviation for that population. 
HS,.., normal (mean, std dev) 
The size of each herd is used in further calculations, as detailed below. 
Herd Contamination 
There is the chance that any given herd may or may not be contaminated with any 
particular hazard. The status of the herd is determined using a Bernoulli trial where the 
probability of success is P(HC) (in the model this is generated as a binomial random 
variate with n=l and p = P(HC)). A herd is contaminated if it contains at least one cow 
with the pathogen or hazard present. For each iteration a herd is 'created' and a test is 
performed which determines if that herd is contaminated for that iteration, given by: 
HC(O,l),.., binomial (1, P(HC)) 
HC takes a value of 1 if the herd is contaminated, or 0 if the herd is _not 
contaminated. The presence of both microbiological and chemical hazards are 
determined in this manner, however for chemical hazards: 
HC(O,l) = HC(Chem),.., binomial (1, P(ChemHaz)) 
This process takes place for each hazard being modelled. Thus, any given herd 
may be free from all hazards, or may be contaminated by a single hazard or by multiple 
/ 
hazards. The model simulates nine hazards during a single run, thus for each farm in the 
model seven microbiological hazards and two chemical hazards are modelled. 
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Number of Contaminated and Uncontaminated Cows 
If a herd is contaminated, the number of cows within that herd which have 
contaminated udders is determined by sampling from a binomial distribution, with the 
number of trials given by the herd size (HS) and the probability that an individual cow's 
udder is contaminated given as P(UCIHC). Hence the number of successes, that is the 
number of cows with contaminated udders, is given by: 
CHs"' binomial(HS, P(UCIHC)) 
To calculate the number of cows that are not contaminated the following equation 
is used: 
UCHs = HS - CHs 
Bacterial numbers and concentration in milk produced by contaminated cattle 
It is assumed that for each contaminated cow all the bacterial cells present that may 
be transferred to the milk are transferred to the milk. This is a simplification, as there 
may be some correlation between the degree of contamination and the proportion of cells 
contaminating the raw milk, but the relationship, if any, is unknown. The number of 
bacteria present in the milk from the contaminated portion of the herd is determined by 
multiplying the contamination from each cow by the number of cows contaminated 
within the hetd, given by: 
CHb = UCL * CHs 
Chemical contamination of cattle udders 
Similarly to bacterial numbers, it is assumed that all chemical contaminants present 
on or within the cattle's udder are transferred to the milk. Rather than using CHb, CCL 
is used instead, thus: 
CCL = UCL * CHs 
Herd Milk production 
The volume of milk produced by each herd is determined using the Central Limit 
Theorem (Vose, 2000). Each cow produces on average µa litres of milk per day, with a 
variance of a/, and the daily milk production for the herd is given by the equation: 
HM"' normal(HS * µa, sqrt(HS)* aa) 
Growth of pathogenic bacteria in the farm milk vat: 
The temperature range in a farm milk vat is expressed as a Triangular distribution, 
with minimum, most likely and maximum expressed as degrees Celsius, and based on 
the opinion of dairy factory quality control officers. The generation time (GT) for each 
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pathogen is determined from a lookup table in the Excel spreadsheet. The lookup table 
values were generated for temperatures ranging from 0°C to 38°C, from models 
developed and used by the University of Tasmania School of Agricultural Science 
Microbiology group for Escherichia coli, Listeria monocytogenes and Staphylococcus 
aureus. For Yersinia enterocolitica, and Bacillus cereus generation time estimates were 
taken from USDA's Pathogen Modelling Program (PMP) as described in section 2.2.1. 
A generic exponential growth rate model was used for Salmonella spp. and 
Campylobacter spp. 
The time that the milk spends in the farm milk vat was described using a triangular 
distribution, with minimum, most likely and maximum values derived from dairy 
production manager's and quality control officer's opinions for the total age of milk 
prior to it being pasteurised. 
Growth is assumed only to occur in farm vats that have milk contaminated with a 
bacterial pathogen. The growth of spoilage organisms is not considered at this time. 
The number of generations of growth is calculated from the following equation: 
Generations = GT* t FV 
The number of bacteria present in the milk vat, determined for each pathogen, is 
given by the equation 
Total Bacteria Present= N0 *2A(GT* tw) 
Where N0 is the initial number of bacteria present. 
Outputs: 
There are two main outputs from this part of the model; the milk produced daily 
from each farm, and the concentration of hazards present in the milk. 
The above steps are used to simulate a population of farms each with a herd of 
dairy cows. These cows produce a quantity of milk daily, with the concentration of 
contaminating hazard known for each farm with growth of bacterial hazards taken into 
account. 
2.5.2 Milk Collection and Transport Module 
Objective: 
To model the collection of farm milk by tankers, and to monitor the dilution effect 
for chemical hazards and potential growth of bacterial hazards during transport. 
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Inputs: 
Variable Description Identifier 
Tanker volume MTvol 
Fann milk volume (for the ith farm) Fvi 
Concentration of hazards in farm milk (for the ith farm) [HazardFMil 
Maximum pickup temperature for milk MaxT 
Temperature of milk in tanker TMr 
Time milk spends in transport from farm to factory TTrans 
Assumptions made within this section of the model: 
• There is no time lapse between the first milk collection and the last, 
therefore, no bacterial growth is possible until the tanker is full 
• Hazards present in the tanker are distributed evenly throughout the entire 
volume of milk. 
• All hazards present in farm milk vats are transferred, without loss, to the 
milk tanker upon collection by the tanker. 
• There is a constant temperature throughout the volume of milk in the farm 
milk vat prior to collection. 
• The milk is at a constant temperature during transportation between the last 
farm collection and delivery at the factory. 
Fa.rm Number: 
Each simulated farm is given a reference number. This has no relation to where 
the farm is in any particular state/region, however the farm number is a relative spatial 
scale, farms with their farm number close together are spatially close together, i.e. Farm3 
and Farm5 are close together, whereas Farml and Farm60 are more distant. Each tanker 
collects sequentially from the farm list, with the first farm being selected randomly from 
the entire population of farms. This implies that within the model any given tanker 
collects from farms within a similar region, or collects from farms that are close together. 
Tanker Number, Size and Filling 
Similarly, each simulated tanker is given a number to distinguish it from the other 
tankers in the model. Three tanker sizes are modelled: small, medium and large. The 
only difference between the tanker sizes is the volume of milk they are able to transport. 
Based on the size of the first farm visited by each tanker, the respective size of that 
tanker is determined. Once the first farm for collection has been selected a logical test is 
performed to determine if the tanker has sufficient capacity to take the milk. That is, a 
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medium farm is only visited by medium and large tankers, small farms by all tanker 
sizes, and large farms only by large tankers 
The first farm visited by the tanker is randomly selected from a distribution 
covering the entire population of farms using the following function: 
First Pickup "'Duniform (l,N) 
Where N is the total number of farms in the population of farms. 
For each tanker, there may be more than one farm that is visited before the tanker 
has been filled. Large tankers collect from a single farm only, small tanker collect from 
several farms until full, however, medium sized tankers may either collect from a single 
farm or until full. A simple test is performed to determine if a tanker is collecting from 
only one farm, as given by: 
Direct "'Binomial(!, 0.8) 
If the return value, Direct, equals 1, then the tanker visits a single farm on that day: 
If the return value equals zero, the tanker visits additional farms until it is filled. 
Milk Collection 
For small tankers and medium tankers that are not "Direct", several farms are 
visited prior to the commencement of transportation of the milk to the factory. Given 
that the volume of milk in the tanker cannot exceed MTv01, the sum of Fvi (where i 
ranges from 1 to n, and n is the number of farms visited by that tanker) gives the total 
volume of milk within the tanker. Collection continues until the following condition is 
met 
n 
MTvol- LFvi ~ 0 
1=! 
Hazard Contamination Level 
The concentration of any given hazard present in farm milk vats is estimated as 
explained in the farm level module. As each tanker collects from each farm, the amount 
of hazard present in the raw milk from that farm is added to the amount of that hazard 
present in the milk tanker. The model accounts for dilution of hazard through the filling 
process of each tanker. The model deals with concentration of hazard; hence, a weighted 
mean is used to determine the final concentration of hazard in the milk contained in the 
tanker. 
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n 
:L [Hazard.fin} Fvi 
Hazad Concentration in Tanker = -1=-1 ------
n 
MTvol- ~Fvi 
Where n is the number of farms collected from. 
Growth of pathogenic bacteria in milk tankers 
The temperature in each milk tanker is modelled using a truncated log-logistic 
distribution function 01 ose, 2000). Initially the parameters were derived by fitting data 
from the questionnaire responses to a log-logistic distribution using @Risk's data 
fitting function with the best RMS fit to the cumulative distribution. The distribution for 
the potential range of temperatures in the milk tankers was truncated to remove values 
less than 0 (minT) and greater than l 7°C (maJCT) as the former is unlikely to be reached 
in most farm milk vats and the latter is considered unlikely, by production managers in 
Australia, unless the milk is collected immediately following the completion of milking. 
The latter also greatly exceeds the regulatory maximum for milk temperature at farm 
collection. 
Similarly to section 2.5.1, the potential growth of bacteria in the tanker was 
calculated. 
Outputs 
There are two outputs from this part of the model; the volume of milk within each 
tanker, and the concentration of hazards in the milk in each tanker. 
The above steps are used to create a set of milk tankers. that independently collect 
milk from the population of farms. The concentration of hazards present is monitored 
and potential growth of bacterial hazards estimated, to give a final concentration of 
hazards present in the milk tanker's volume of milk at the point of delivery at the 
factory. 
2.5.3 Factory Collection 
Objective: 
To model the collection of milk from tankers by factories and to monitor the 
concentration of both bacterial and chemical hazards present in that pooled milk. 
Inputs 
Variable Description Identifier 
Factory Silo volume FSV 
Milk tanker volume MTv 
Concentration of hazard in tanker milk [HazardMTJ 
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Assumptions made with this section of the model: 
• There is no time lapse between the first tanker delivering milk to the 
factory and the last, that is, there is no microbiological growth occurring 
during silo filling. 
• Hazards present in the silo are distributed evenly throughout the entire 
volume 
• All hazards present in the raw milk in the milk tankers are transferred into 
the factory milk silo. 
• There is insufficient time for growth of bacterial cells in the silo. 
Potential growth has been accounted for in the two previous growth phases, time 
spent in farm milk vat and transport. These two phases account for the entire age of the 
milk as derived from the results of the questionnaire. For the purposes of modelling, 
the time spent in the farm milk vat and in transport also includes the time the milk is held 
in the factory silo. This approach was used because of the limitations of the data 
obtained from the questionnaire. Consequently, potential growth in the silo is not 
modelled discretely but is incorporated in potential growth during the two previous 
stages. 
For each product that is modelled three factories are simulated. That is for liquid 
milk there is a 'large', 'medium' and 'small' factory simulated, similarly for cheese and 
powdered milk. 
Factory Size 
For each product being modelled there are three factory sizes used: 'small', 
'medium' and 'large'. The volume of milk that each factory can collect daily is 
determined by a Triangular (min, most likely, max) distribution. The factory sizes differ 
only in their capacity to process milk. There was no difference in risk expected between 
factories of different sizes. However, given knowledge of factory size specific risks, the 
model is capable of incorporating that new knowledge without needing restructuring. 
Milk Collection 
Given that the volume of milk in the tanker cannot exceed the volume of milk the 
factory silo may contain: if Tvmin > FSv, (where Tvnun is the minimum volume of milk 
contained in the tankers) is true then no collection occurs on that day for that factory, if 
this is false then milk is simulated to be collected in a manner similar to that described in 
section 2.5.2. 
Hazard Contamination Level 
The concentration of any given hazard present in factory milk silo is determined in 
a manner similar to that for each tanker. As each tanker delivers milk to the factory, the 
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amount of hazard present in the raw milk from that tanker is added to the amount of that 
hazard present in the factory silo. The model deals with concentration of hazard; hence, 
a weighted mean is used to determine the final concentration of hazard in the milk 
contained in the silo. 
11 ~ [Hazardtm ]x Tvi 
HazardConcentration = -1=-------
FSvol 
where n is the number of tankers collected from. 
Outputs 
There are two outputs from this section of the model: the volume of milk in the 
each silo and the concentration of hazard present in the silo. 
This part of the model simulates the delivery of milk to the factory by the tankers 
simulated in the previous section. The volume of milk entering the silo, daily, i_s 
monitored also the concentration of both chemical and microbiological hazards. 
2.5.4 Pasteurisation 
Objective 
To model the effect of pasteurisation on the hazard concentration of milk in the 
factory silo. 
Inputs 
Variable Description Identifier 
Pasteurisation temperature PsTemp 
. Pasteurisation time Pst 
Log-linear thermal reduction parameters a, b 
Assumptions made with this section of the model: 
• 
• 
• 
• 
Log-linear thermal inactivation of vegetative bacterial cells present 
Chemical hazards present are not affected by pasteurisation conditions 
Entire volume of milk is subjected to the same temperature and time 
Bacillus cereus - all vegetative cells are assumed to have sporulated prior to 
pasteurisation. 
For each product simulated, the pasteurisation conditions can be changed to suit 
the process for that particular food item. 
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The concentration of hazards present in the factory silo is calculated from 
calculations described in section 2.5.3. 
Effect of Pasteurisation on Hazards present in Milk 
The concentration of bacteria present in the milk after it has been pasteurised is 
calculated from the initial concentration, the log-reduction from thermal pasteurisation 
(D value is the time in seconds to reduce the population of bacterial cells by one log 
cycle) and the pasteurisation conditions. The log-linear thermal death equation (Huang 
and Juneja, 2001) for bacterial pathogens is of the form 
Log10(D) =(-a* PsTemp) + b 
Therefore 
D = 1QA((-a * PsTemp) +b) 
Where a and b are regression parameters for the log-linear line of best fit, and D 
is time, in seconds, to reduce the bacterial population by one log, or 90%. 
Hence, the total log reduction (TLR) during the time that milk is pasteurised is 
given as: 
TLR = Pst/(lQA((-a * PsTemp) +b)) 
=Pst/D 
The concentration of pathogenic bacteria present in the milk after pasteurisation is 
calculated as: 
Remaining bacterial concentration = Initial Concentration/ TLR 
Outputs 
There is one output from this section of the model, the concentration of bacterial 
pathogens in the product after pasteurisation. For products other than liquid milk, the 
pasteurisation step occurs prior to further processing steps. Hence the concentration of 
pathogens present after pasteurisation is that in the milk used for further processing. 
2.6 Model Implementation and Execution 
The model was developed on a Microsoft Windows based computer running 
Excel 2000 (Microsoft Corporation) and @Risk v4.05 and later @Risk v4.5 (Palisade 
Corporation). The model was designed to be as flexible as possible without 
compromising the logic steps within, that is, allowing the ability to update the model to 
incorporate new data. As a consequence of this a standard template was designed to 
enable manipulation of the input distributions without changing the structure of the 
model. The inputs and outputs of each part in the model are clearly marked within the 
\ 
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spreadsheet. The model itself comprises a series of linked Excel spreadsheets, with each 
sheet describing part of the farm-to-factory pathway as disclJssed above. A stochastic 
approach was used to run simulations of the model. For each simulation 30 OOO 
iterations were run using Jatin hypercube sampling 01 ose, 1996). 
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3. Results 
3.1 Hazard Identification 
The hazards that may be present in dairy products were identified in the literature 
review (section 1.7) 
3.2 Hazard Characterisation 
The characteristics of adverse health effects associated with the identified hazards 
are detailed in the literature review (Section 1.8), which includes the dose response 
relationship for the high priority bacterial pathogens and some information regarding the 
Australian regulatory maximum allowable limits for antibiotics and herbicides. 
3.3 Thermal death kinetics of pathogenic microorganisms 
A description of the log-linear thermal inactivation for each of the bacterial 
pathogens examined follows. Graphs showing the thermal inactivation data for each 
organism are Log D (seconds) against temperature (°C). Data sources, together with the 
raw data for all examined pathogens are listed in Appendix C. 
Escherichia coli 
The thermal inactivation kinetics of E.coli has been described in many· papers. A 
single paper described the thermal inactivation of E.coli in milk (D' Aoust et al, 1998) 
with the majority of the published accounts describing inactivation in meat products or in 
liquid media. The plot for log10(D) vs. temperature for E. coli is given (Fig 3.1) 
showing the pooled data from all the papers examined. The log-linear line of best fit is 
also shown including the regression parameters. The majority of papers describe the 
heat inactivation of E. coli 0157. Because this organism is the most important of the 
EHEC group it was assumed to be representative of the kinetics of all EHEC organisms. 
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Figure 3.1 Pooled thermal inactivation data for Escherichia coli 
Listeria monocytogenes 
The thermal inactivation kinetics of Listeria monocytogenes has been examined in 
several media including milk, meats, vegetables and laboratory media. A plot of the 
pooled data including the log-linear regression line, gathered from the published 
literature, is shown (Fig 3.2) and a subset of that data related to liquid milk thermal 
inactivation studies only shown in Fig 3.3. 
Figure 3.2 Pooled thermal inactivation data for Listeria monocytogenes 
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Figure 3.3 Subset of thermal inactivation data for Listeria monocytogenes limited to 
liquid milk as the medium for investigation 
The subset of the pooled milk data is used as the thermal inactivation relationship 
for Listeria nionocytogenes in the pasteurisation step of the model (refer to section 
2.5.4) 
Salmonella spp 
No published literature were found that described the thermal inactivation of 
Salmonella spp in liquid milk, or other dairy products. A single paper described the 
thermal inactivation in eggs (Schuman and Sheldon, 1997) whereas others looked at 
either laboratory media or meat products (chicken, turkey, and beef). The pooled 
thermal inactivation data for Salmonella spp is shown (Fig 3.4). 
There is a poor fit for the log-linear thermal inactivation model, compounded by 
the lack of relevant data for dairy products. In the plot of logD vs temperature there 
appears to be two divergent thermal inactivation curves. This is an artefact of the use of 
several different datasets and gives some indication of the variability in the thermal 
resistance of Salmonella spp. 
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Figure 3.4 Pooled thermal inactivation data for Salmonella spp. 
Campylobacter spp 
There are few papers in the literature that deal with the thermal inactivation of 
Campylobacter species. Assuming that the thermal inactivation kinetics of 
Campylobacter jejun_i and C. coli are similar, a log-linear model was constructed for 
these organisms (Fig 3.5). Little data exists for the thermal inactivation of 
Campylobacter spp in liquid milk 
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Figure 3.5 Pooled thermal inactivation data for Campylobacter spp. (C.jejuni in dark 
points, C. coli light points) 
Yersinia enterocolitica 
Little information exists for the thermal inactivation of Y. enterocolitica. Four 
papers were found to describe the log-linear thermal kinetics of this organism from 
Results 68 
experimental data. Of these, two describe inactivation in milk (D'Aoust et al, 1988; 
Toora et al, 1991); however, there is insufficient information to construct a model from 
these data alone. The pooled thermal inactivation data is shown (Fig. 3.6). 
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Figure 3.6 Pooled thermal inactivation data for Yersinia enterocolitica 
Staphylococcus aureus 
A description of the thermal tolerance of Staphylococcus aureus is found in 
ICMSF (1996). Several different media were used to determine this organism's thermal 
tolerance. The pooled "data (Fig 3.7) shows a poor fit to the simple log-linear thermal 
inactivation model. However, if a subset of that data is taken such that only the 
observation specific for milk are taken the fit improves (Fig 3.8) 
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Figure 3.7 Pooled thermal inactivation data for Staphylococcus aureus 
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Figure 3.8 Single dataset for thermal inactivation for Staphylococcus aureus, liquid milk 
Bacillus spp 
No published thermal inactivation studies for vegetative cells of Bacillus cereus 
were found. The papers examined describe the inactivation for the spores of this species 
and other Bacillus species. Normal pasteurisation temperatures are insufficient to 
inactivate spores from this organism (Leontidis et al, 1999). The thermal inactivation 
plot for Bacillus spores is shown in Fig 3.9. 
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Figure 3.9 Thermal inactivation dataset for Bacillus spores (Leontidis et al, 1999) 
A summary of the parameters for the log-linear thermal inactivation kinetics for 
each organism is presented in Table 3.1. 
Table 3.1 Thermal inactivation parameters derived from pooled data 
Organism a b R~ D 
E.coli 0.1638 11.855 0.723 
Listeria monocytogenes (all 0.1367 10.352 0.742 
data) 
(liquid milk data) 0.1544 11.408 0.960 
Salmonella 0.1021 8.1974 0.503 
Campylobacter spp 0.1429 9.691 0.782 
Yersinia enterocolitica 0.1523 10.584 0.915 
Staphylococcus aureus (all 0.0947 7.752 0.994 
data) 
(liquid milk data) 0.1062 8.086 0.994 
Bacillus spp (spores) 0.1267 17.748 la 
a based on model predictions for B. stearothermophilus (Leontidis et al, 1999) 
b R2 is the linear regression coefficient 
3.4 Consumption patterns of dairy products in Australia 
The Australian dairy industry produced 10.17 billion litres of raw milk in the 
1999/2000 financial year. This is an increase in production from 8206 million litres in 
1994/95. Approximately 20 - 25% of the raw milk produced in Australia is used as 
drinking milk; the remainder is used for the manufacture of other dairy products. 
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Estimates by the Australian Dairy Corporation (ADC) on consumption of liquid milks 
in Australia, show a slight change from ,..., 105 litres consumed per person annually to 
"'102 litres, in the same period. A detailed look at consumption patterns of dairy 
products in Australia follows with comparisons between estimates provided by the ADC 
and the figures presented in a survey conducted by the Australian Bureau of Statistics 
(ABS, 1997). 
Product Groups 
To characterise more accurately the risk associated with dairy products, it is 
important to know the total volume of products consumed, the type of product and the 
form in which it is consumed, the frequency of consumption, the volume consumed per 
person and, if possible, differences in consumption among different sub-groups in the 
Australian population based on age, gender and health status. The National Nutrition 
Survey (NNS), conducted by the Australian Bureau of Statistics (ABS) in 1995, 
provides a detailed examination of the consumption patterns of all foods groups, 
including dairy, by the Australian population (ABS, 1997). The information presented 
in the NNS is split into broad food group and within each category there are individual 
product types or groups. The dairy product groups are shown (Table 3.2a). 
1 
2 
3 
4 
5 
6 
7 
8 
Table 3.2a Categories for Milk products and dishes in the 
National Nutrition Survey 
NSS Group Products Included 
Dairy Milk Drinking milk, including full fat, fat increased, low 
fat, condensed, evaporated and powdered 
Yoghurt Natural, flavoured, low fat, buttermilk, yoghurt 
drinks 
Cream Thickened, sour, reduced fat, artificial 
Cheese Natural, reduced fat, cottage, cream, processed, 
camembert, brie and cheese dishes 
Frozen milk products Ice creams (all types), frozen yoghurts, thick 
shakes, frozen dairy desserts 
Other dishes where milk or a milk Custards, sweet sauces, dairy desserts, cheese-, 
product is a major component milk- and cream-based desserts 
Milk substitutes Soy beverages and ice confection, and non-dairy 
cheese substitutes 
Flavoured Milks Flavoured full fat, low fat and unspecified fat level 
The NNS food groups were chosen to reduce statistical uncertainty, however, 
these food groups span different product groups from the ADC and DRDC production 
figures, which leads in some cases to apparent difference in consumption estimates. To 
accommodate this difference the ABS survey groups have been used and, where 
possible, the ADC production figures correlated with the ABS product groups. 
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Consumption Data 
Australia's population of ,....,19.5 million consume ,....,4_3 million litres of milk per 
day, with ,....,400 OOO litres being flavoured milks, around 252 tonnes of cheese and ,....,250 
tonnes of yoghurt. This equates to approximately 400g of dairy products per person per 
day, or 2 million tonnes of dairy products consumed annually throughout the nation. 
The consumption data is divided into three forms. Firstly the total annual 
consumption of Australian dairy products, secondly the consumption patterns for 
specific age groups, split between males, females and persons as presented in the ABS 
survey, and thirdly by state and territory. C~msumption data by state and territory has 
been compiled for those persons aged 19 and over. This accounts for ,....,68% of the total 
daily consumption or ,....,75% of the population. It is important to note that when using 
the state and territory consumption figures that a large part (,....,25%) of the consumption 
for that state has not been included, i.e. consumption attributable to those people aged 
less than 19 years of age. Consumption estimates from the DRDC and ADC have used 
supermarket sales as an indication of consumption. This assumes that the population 
consumes all dairy products sold through supermarkets. The loss of products due to 
spoilage, poor handling, and feeding to pets is not known; hence, these consumption 
figures may overestimate the true consumption pattern of dairy products in Australia 
(see Table 3.2). Conversely, the proportion of sales direct to door and through small 
retail outlets is ignored. 
The annual consumption of dairy products in Australia was calculated using the 
daily consumption figures for each age group (ABS, 1997), based on the estimated 
population for each age group (see Appendix B), added together and multiplied by· 365 
(days in the year) as presented in Table 3.2. A comparison of the DRDC and ADC 
production and consumption statistics for the 1995/96 financial year has also been 
included. This table summarises the consumption for each NNS product group and 
where possible, the ADC production and consumption data has been entered as a 
comparison. Table 3.2 shows that there are gaps in the information that is currently 
available. 
Estimates of annual consumption from the ABS survey indicate that drinking milk, 
flavoured and plain, is the most frequently consumed dairy product in Australia with an 
annual consumption of 1.6 billion litres. This correlates well with the ADC production 
figure of 1.9 billion litres and the ADC consumption estimate of 1.6 billion litres. A 
similar pattern can be seen for yoghurt, cheese, and frozen milk products, the next most 
commonly consumed dairy products. The remainder of the product groups lack key 
data to enable this comparison to be performed. 
The bulk of the information presented in the NNS survey (ABS, 1997) is 
condensed in the following tables and figures. The mean daily intake of dairy products, 
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by fine age group (shown in Figure 3.10), indicates a gradual decrease in the daily 
consumed volume with increasing age, with consumption ranging from ~500 grams per 
day in young children down to ~250g in the elderly population. Table 3.4 shows the 
breakdown by product category for mean daily consumption by fine age group. The 
mean consumption of dairy products by state and territory for persons aged 19 and over 
is between 250 and 350 grams per day (Figure 3.1 1.). Table 3.5 provides a detailed 
summary of the daily consumption by state and territory for persons aged 19 and over. 
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Table 3.2b - Total annual consumption of Australian dairy products 
Frozen Milk 
Dairv Milkb Yoehurt" Cream Cheese• 
All Ages ABS stats (95/96) l.45E+09 9.06E+07 l.55E+07 9.20E+07 based on population of 
17564932 
Production Figures from ADC 
(95/96) - l.89E+09 9.32E+07 ND 2.41E+08c 
Consumption Figures from 
ADC (95/96) 1.75E+09 7.97E+07 2.10E+08d 9.38E+07° 
Export Volumes 6.6E+07 2.0E+06 ND 1.11E+08 
Volume Unaccounted for' 7.60E+07 1.15E+07 - 3.58E+07 
Percentage of Production 
Remaining' 4.0% 12.3% - 14.9% 
a - values m kg 
b - values m litres 
c - includes all cheese types 
d - data has been taken from 1993/94 financial year due to discontinuation of series in 1995/96. 
e - only mcludes Australian produced cheeses, imports have been excluded 
f - NNS survey includes buttermilk. No data for buttermilk production m the ADC statistics. 
g - Export volume based on ADC figures 
Products 
l.52E+08 
2.03E+08d 
2.00E+08d 
ND 
2.30E+06 
1.1% 
Other Dishes where 
milk or a milk 
product is a major 
component 
8.30E+07 
ND 
3.02E+07 
ND 
-
-
h - Calculates the volume of product remaining from the ADC production figures after consumption and export have been subtracted 
i - gives the percentage of production volume unused 
ND - indicates no specific data 
" 
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Milk Flavoured 
Substitutes Milksb 
3.09E+07 1.32E+08 
ND ND 
ND l.43E+08 
ND ND 
- -
- -
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Table 3.4 - Daily consumption of dairy products in Australia by fine age group (ABS, 1997) 
Mean 
Total 
Intake" 
2-3 487.9 
14-7 381.3 
8-11 394.1 
12-15 421.4 
16-18 417.5 
19-24 - 332 
25-44 294.2 
145-64 275.l 
65 and over 267.8 
rrotal Dairy 
Products 
Consumed 
IDailv 3271.3 
a - Values in grams 
b - Values in litres 
c - Values in kg 
Population Total 
size Consumption of Dairy 
Estimate Dairy Products• Milkb 
517536 2.53E+05 2.01E+05 
1031614 3.93E+05 2.86E+05 
1032682 4.07E+05 2.93E+05 
1019896 4.30E+05 2.99E+05 
757948 3.16E+05 2.19E+05 
1699348 5.64E+05 3.75E+05 
5592190 l.65E+06 l.13E+06 
3752980 l.03E+06 7.57E+05 
2160738 5.79E+05 4.27E+05 
3.99E+O 
17564932 5.62E+06 6 
Other Dishes 
where milk or a 
Frozen milk product is Milk 
Milk a major SubstitutesFlavoure 
Yo~hurtc Crea me Cheesec Productsc componentc c d Milksb 
9.57E+03 2.59E+02 5.59E+03 8.75E+03 l.27E+04 8.54E+03 6.31E+03 
l.46E+04 4.13E+02 1.13E+04 3.33E+04 2.31E+04 3.82E+03 2.02E+04 
1.23E+04 1.03E+03 1.29E+04 4.96E+04 l.41E+04 4.44E+03 2.01E+04 
l.55E+04 l.33E+03 1.48E+04 6.00E+04 l.17E+04 l.53E+03 2.59E+04 
l.37E+04 l.59E+03 l.42E+04 3.19E+04 6.06E+03 O.OOE+OO 2.95E+04 
1.63E+04 4.59E+03 2.72E+04 3.99E+04 1.72E+04 7.31E+03 7.65E+04 
8.00E+04 l.68E+04 9.17E+04 l.06E+05 5.31E+04 2.63E+04 l.43E+05 
5.52E+04 1.01E+04 5.29E+04 6.00E+04 4.28E+04 1.91E+04 3.57E+04 
3.09E+04 6.48E+03 2.14E+04 2.66E+04 4.67E+04 1.36E+04 5.83E+03 
3.63E+O 
2.48E+OS 4.26E+04 2.52E+OS 4.16E+OS 2.28E+05 8.47E+04 5 
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Table 3.5 - Daily consumption of dairy products in Australia by state and territory for'persons aged 19 and 
over(ABS, 1997) 
Other Dishes 
where milk or a 
Mean Population Total Frozen milk product is Milk 
Total size Consumption of Dairy Milk a major Substitute Flavoure 
Intake" Estimate Dairy Products Milkb Yoghurt" Crea me Cheesec Productsc component" Sc d Milksb 
NSW 268.4 4541092 l.22E+06 8.75E+05 5.45E+04 1.09E+04 6.04E+04 7.36E+04 5.31E+04 2.45E+04 6.63E+04 
Vic 285.3 3325795 9.49E+05 6.86E+05 5.06E+04 l.16E+04 5.15E+04 5.55E+04 3.53E+04 1.70E+04 4.09E+04 
QLD 306.l 2407414 7.37E+05 5.27E+05 3.44E+04 5.30E+03 3.39E+04 5.06E+04 3.39E+04 8.67E+03 4.31E+04 
SA 326.1 1062165 3.46E+05 2.18E+05 1.27E+04 4.14E+03 1.86E+04 1.91E+04 l.27E+04 4.04E+03 5.70E+04 
I 
1
WA 311.2 1226002 3.82E+05 2.49E+05 2.17E+04 3.80E+03 1.84E+04 2.10E+04 l.78E+04 9.69E+03 4.08E+04 
las 269.J 336449 9.05E+04 6.59E+04 5.05E+02 l.58E+03 4.51E+03 6.16E+03 4.37E+03 7.74E+02 3.33E+03 
NTd 
- 105305 
ACT 312.4 201035 6.28E+04 4.37E+04 3.82E+03 6.03E+02 3.76E+03 4.58E+03 l.65E+03 l.07E+03 3.56E+03 
iTotal Dairy 
Products 2.67E+O 2.55E+O 
Consumed 2078.6 13205257 3. 79E+06 6 1. 78E+05 3.80E+04 1.91E+05 2.30E+05 1.59E+05 6.57E+04 5 
a - Values m grams 
b - Values in lttres 
c - Values in kg 
d - data for Northern Territory is included in Australian totals m NNS survey 
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3.5 Model Inputs 
The inputs parameters used in the model are detailed in this section. The majority 
of the values listed derive from the survey data (Appendix D). A few of the derived 
values are from published reports on the prevalence of pathogens in dairy herds 
(Rohrbach et al, 1992; Coia et al, 2001; Jayarao and Henning, 2001). The inputs used 
for the farm level module are presented in Table 3.6, indicating both the parameter values 
and the distribution sampled from for each iteration, similarly for the milk collection and 
transport module (Table 3.7), and the Factory module (3.8). 
The input parameters for the thermal inactivation model used for the pasteurisation 
section of the model are presented in Table 3.1. The pasteurisation conditions for the 
two products that have been modelled are 15-30s 75-78°C for liquid milk production 
and 15-25s at 73-78°C for cheese production. Pasteurisation conditions do not differ 
widely between different product lines in Australia. In terms of the model, the milk that 
is received at each of the factories is assumed to be pasteurised by that factory. Any 
further processing occurs after the point of pasteurisation. 
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Table 3.6 Input Parameters: distributions and values for the farm level module 
Input Distribution Parameter Units Source 
value(s) 
P(LF) Beta (al, a2) al-40 - NSW survey 
Prob. Large farm a2-519 data 
P(MF) Beta (al, a2) al -367 - NSW survey 
Prob. medium farm a2-192 data 
Herd Size LF Normal(µ, a) µ-390 Cows NSWsurvey 
a-75 data 
Herd size MF Normal (µ, a) µ-174 Cows 
a-30 These inputs are 
Herd Size SF Normal(µ, a) µ-70 Cows rounded to whole 
a-15 number values 
P(HC) E. coli Beta (al, a2) al -21 - Coia et al, 
Prob. Herd contaminated a2-1832 2001; Steele et 
P(HC) Listeria Beta (a 1, a2) al-66 - al, 1997; 
a2-2079 Rohrbach et al, 
P(HC) Salmonella Beta (al, a2) al-38 - 1992; Jayarao 
a2-2107 and Henning, 
P(HC) Yersinia Beta (al, a2) al-53 2001 -
a2-372 
P(HC) Beta (al, a2) al -57 -
Campylobacter a2-2088 
P(HC) Bacillus Triang (min, Min-0 - Estimated value 
most-likely, ML-0.5 
max) Max-0.6 
P(HC) S. aureus Triang (min, Min-0 - Estimated value 
most likely, ML-0.5 
max) Max-0.6 
P(ChemHaz) Gamma(a, !)) a-195 - AMRA,2001 
Antibiotic 1)-7.98 x 10"6 
P(ChemHaz) Beta (al, a2) al-1 - AMRA,2001 
Pesticide a2-83 
P(UCIHC) Uniform (min, Min-0.1 - Assumed value 
max) Max-0.2 
Chb (all pathogens) Fixed value 100 Cells Assumed value 
CCL (all chemical Fixed value 0.1 Grams Estimated value 
hazards) 
Milk production per Normal (µ, a) µ-20 Litres Expert opinion 
COW a-5 
TFV Triang (min, Min-1 oc NSW Survey 
Temperature in farm vat most likely, ML-4 data 
max) Max-6 
tFV Triang (min, Min-1 Hours NSW Survey 
time spent in farm vat most likely, ML-16 data 
max) Max-72 
P(> compliance Beta (al, a2) al-40 - NSW Survey 
temperature) a2-262 data 
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Table 3.7 Input Parameters: distributions and values for the milk collection and 
transport module 
Input Distribution Parameter Units Source 
value(s) 
Tanker volume Fixed value Small 10000 Litres Expert opinion 
Medium 20000 
Large40000 
MaxT Fixed value 17 oc NSW survey 
Max. temperature in data 
tanker 
TMT Log-Logistic y- 1.1499 oc NSW survey 
Temperature in milk (y, (3, a) (3-2.7994 data 
tanker a-2.6358 
TTrans Triangular Min-1 Hours Expert opinion 
Time spent in milk (min, ML-4 
tanker mostlikely, Max-18 
max) 
Table 3.8 Input Parameters: distributions and values for the factory module 
Input Distribution Parameter Units Source 
value(s) 
Factory silo volume Pert (min, most Min-1 OOO L NSW Survey 
Small likely, max) ML-5000 data 
Max-10000 
Medium Min-10 OOO L 
ML-40000 
Max-600 OOO 
Large Min-500 OOO L 
ML-1 OOO OOO 
Max - 2 OOO OOO 
3.6 Farm Level Module 
In the final draft of the model 1000 farms were modelled. In a simulation with 
30000 iterations, the mean number of farms in each class (small, medium and large) was 
72, 609 and 319 respectively. The mean milk production from these farms was 
estimated to be 3 126 OOO (51h percentile 2 987 OOO, 951h percentile 3 270 OOO) litres per 
day, being produced from a mean total herd size of 156 OOO (51h 149 OOO, 951h 164 OOO) 
cows. There were 268 OOO cows in NSW in 2000, including both cows "in milk" and 
"dry", "'60% of the dairy herd is "in milk". These cows produced around 3.5 million 
litres of raw milk per day. Thus from the 1000 farms (86% of total farms) that are 
modelled, 87% of the daily milk production is accounted for from ,..,57% of the total 
herd size in NSW. The initial, estimated mean contamination of raw milk with 
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microbiological and chemical hazards, with associated confidence intervals, is presented 
in table 3.9. 
Table 3.9 Estimated mean concentration of hazards in raw milk. 
Hazard Mean 5 % Percentile 95% Units 
Percentile 
E.coli 8.51 x 10-" 3.50 x 10-;) 1.52 x 10-.0 Cells/L 
Salmonella spp 1.33 x 10-2 6.60 x 10-3 • 2.19 x 10-2 Cells/L 
L. monocytogenes 2.31x10-2 1.33 x 10-2 3.54 x 10-2 Cells/L 
Y. enterocolitica 9.36 x 10-2 5.94 x 10-2 0.134 Cells/L 
C.jejuni 1.99 x 10-2 1.11x10-2 3.11x10-2 Cells/L 
B. cereus 0.275 8.71x10-2 0.467 Cells/L 
S. aureus 0.275 8.61 x 10-2 0.466 Cells/L 
Antibiotic 1.17 x 10-6 0.00 3.06 x 10-6 Grams/L 
Pesticide 8.93 x 10-6 0.00 2.76 x 10-5 Grams/L 
The concentration of microbiological hazards in the raw milk is affected by the 
storage conditions in the farm milk vat in the event that these conditions permit the 
growth of the organisms present. Table 3.10 shows the estimated mean concentration of 
microbiological hazards after storage in the farm milk vat. 
Table 3.10 Concentration of microbiological hazards present in the farm milk vat 
after storage 
Hazard Mean 5 % Percentile 95% Units 
Percentile 
E.coli 3.13x10-.0 4.18 x 10-" 0.111 Cells/L 
Salmonella spp 5.29 x 10-2 8.89 x 10-3 0.162 Cells/L 
L. monocytogenes 0.752 3.32 x 10-2 2.93 Cells/L 
Y. enterocolitica 94.3 5.24 299 Cells/L 
C.jejuni 1.99 x 10-2 1.11x10-2 3.10 Cells/L 
B. cereus 4.88 1.04 9.95 Cells/L 
S. aureus 0.275 8.64 x 10-2 0.467 Cells/L 
By varying the udder contamination level (UCL, CCL), the concentration of the 
hazards present in the farm milk vat changes in proportion to the change in the 
contamination level. That is, if 10 OOO cells enter the milk through each contaminated 
cow, the concentration of bacteria in the farm milk vat prior to the growth phase is 100 
times greater than with the initial contamination level of 100 cells per cow. 
The change in concentration of the hazards present in the farm milk vat varied 
from none, for antibiotics, pesticides, C. jejuni and S. aureus, up to 103 for Y. 
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enterocolitica. Table 3.11 shows the log10 change in the mean concentration of all 
hazards in ascending order. 
Table 3.11 Mean increase in hazard concentration between the farm milk vat and 
up to prior to collection by the milk tanker 
Hazard Mean Log10 Increase 
Campylobacter jejuni 0 
Staphylococcus aureus 0 
Antibiotic 0 
Pesticide 0 
Escherichia coli 0.566 
Salmonella spp 0.600 
Bacillus cereus 1.25 
Listeria monocytogenes 1.51 
Yersinia enterocolitica 3.00 
For each organism the estimated increase due to growth can be attributed to the 
ability of that organism to grow, or not, in low temperature environments, and the 
probability that each farm's milk vat will exceed the regulatory temperature limit and 
allow growth of non-psychrotrophic organisms. Growth shifts the estimated cumulative 
distribution of the concentration of hazard to the right 
3. 7 Mille Collection and Transport Module 
In the final draft of the model 50 tankers were modelled. In a simulation with 
30000 iterations, the mean volume of milk collected by these tankers was estimated to be 
681 OOO litres per day. The estimated mean contamination of raw milk with hazard in 
the milk tankers, with associated confidence intervals, is presented in table 3.12. 
Table 3.12 Estimated mean concentration of hazards in raw milk present in the 
milk tanker 
Hazard Mean 5 % Percentile 95% Units 
Percentile 
E.coli 3.21x10-2 0.00 0.112 Cells/L 
Salmonella spp 5.11x10-~ 5.31x104 0.189 Cells/L 
L. monocytogenes 0.767 5.32 x 10-3 2.96 Cells/L 
Y. enterocolitica 86.5 0.129 393 Cells/L 
C.jejuni 2.00 x 10-2 2.39 x 10-3 4.99 x 10-2 Cells/L 
B. cereus 0.275 8.04 x 10-2 0.481 Cells/L 
S. aureus 5.64 x 10-2 2.09 x 10-3 0.190 Cells/L 
Antibiotic 1.64 x 10-6 0.00 5.93 x 10-6 Grams/L 
Pesticide 8.89 x 10-6 0.00 3.63 x 10-5 Grams/L 
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The concentration of the microbiological hazards present in the raw milk is 
affected by the storage conditions in the milk tanker as it transports the milk from the 
farms to the fa_(;tory. Table 3.13 shows the estimated mean concentration of these 
hazards after the transportation. 
Table 3.13 Concentration of microbiological hazards present in the milk tanker 
after transportation 
Hazard Mean 5 % Percentile 95% Units 
Percentile 
E.coli 3.68 x 10-~ 0.00 0.117 Cells/L 
Salmonella spp 5.76 x 10-2 0.00 0.205 Cells/L 
L. monocytogenes 1.01 4.34 x 10-3 3.24 Cells/L 
Y. enterocolitica 158 0.138 565 Cells/L 
C.jejuni 2.00 x 10-2 1.63 x 10-3 5.37 x 10-2 Cells/L 
B. cereus 0.357 9.46 x 10-2 0.659 Cells/L 
S. aureus 5.83 x 10-2 1.58 x 10-3 0.192 Cells/L 
During transportation the model predicts that there will be bacterial growth, 
however, the amount of growth is not estimated to be as great as within the farm milk vat 
This is due to the smaller amount of time available for growth to occur. Table 3.14 
shows the log10 change in the concentration of the microbiological hazards present in the 
tanker from the point of collection at the farm to just prior to delivery at the factory. 
Table 3.14 Change in mean hazard concentration in the milk tanker between farm 
pickup and factory delivery 
Hazard Mean Log10 Increase 
Antibiotic 0.00 
Pesticide 0.00 
Campylobacter jejuni 0.00 
Staphylococcus aureus 0.014 
Salmonella spp 0.052 
Escherichia coli 0.061 
Bacillus cereus 0.113 
Listeria monocytogenes 0.120 
Yersinia enterocolitica 0.262 
All microbiological hazards are predicted to increase during transportation. There 
is an increase in the spread of the distribution of the mean concentration for each hazard. 
This means that there is an increased, though small, .probability of encountering an 
increased number of pathogens. Corresponding to this is the reduced, though still large, 
probability of encountering a small number of pathogens. For example, the estimated 
probability of encountering less than 20 cell/L of Yersinia enterocolitica in the farm 
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milk vat just prior to collection by the tanker and in the tanker after transportation is 0.65 
and 0.64 respectively, whereas the probability of encountering greater than 1000 cells 
per litre is 0.015 and 0.028. 
3.8 Factory Level Module 
In the final draft of the model 3 factories were modelled for each product, those 
products being; liquid milk, cheese, and milk powder. The mean total daily milk 
collection for all factories was estimated to be 2 020 OOO litres. This is greater than both 
the daily milk production at the farm level and the daily milk collection by the tankers. 
However, for a single product the factory collection (i.e. 3 factories) is "'500 OOO litres 
per day. The model does not differentiate between tankers that have delivered milk and 
those that have not. Thus on a single iteration a single tanker may deliver milk to both 
the "large milk powder factory" and the "small cheese factory". 
The estimated concentration of all hazards modelled after the daily collection of 
milk at the factory is shown in table 3.15. 
Table 3.15 Estimated mean concentration of hazards in raw milk present in the 
factory silo 
Hazard Mean 5 % Percentile 95% Units 
Percentile 
E.coli 2.94x 10-" 0.00 9.81 x 10-" Cells/L 
Salmonella spp 4.82 x 10-2 0.00 0.156 Cells/L 
L. monocytogenes 0.801 3.82 x 10-3 2.76 Cells/L 
Y. enterocolitica 140 0.103 426 Cells/L 
C.jejuni 1.69 x 10-2 1.42 x 10-3 6.45 x 10-2 Cells/L 
B. cereus 0.3046 6.05 x 10-2 0.732 Cells/L 
S. aureus 4.37 x 10-2 0.00 0.159 Cells/L 
Antibiotic 1.01x10-6 0.00 4.14x 10-6 Grams/L 
Pesticide 7.56 x 10-6 0.00 9.94 x 10-5 Grams/L 
The mean concentration of the antibiotic and pesticide modelled are below the 
regulatory limit. However, the distribution about the mean for these concentrations 
spans several orders of magnitude, with the maximum concentration, for the antibiotic 
and pesticide respectively, of 2.35 x 10-4 g/L (0.24 mg/L) and 4.92 x 10-4 g/L (0.49 
mg/L). The most commonly used antibiotic in the Australian dairy industry is 
neomycin; its MRL is 0.5 mg/kg (DFSV, 2001). It was not detected in 476 samples 
taken in a recent survey for antimicrobial residues, i.e. the observed probability of 
detection is less than 2.1 x 10-3 (ADASC, 2001). The estimated mean concentration of 
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antibiotic residues in the factory silo of 1.01 x 10-3 mg/L is around 4500 times smaller 
than the MRL for this antibiotic. The modal value was zero. Detections of antibiotic 
residues in factory silos have occurred in about 0.04% of samples taken. The model did 
not predict that these substances would exceed the MRL. With the exception of L. 
monocytogenes and Y. enterocolitica, the microbiological hazards may be present at an 
average concentration of less than one cell per litre. 
3.9 Pasteurisation Module 
The estimated likely contamination of pasteurised milk with the microbiological 
hazards modelled, is negligible, effectively zero (Table 3.16). There was no data 
available to validate these estimates. The simulation output of predicted mean 
concentration for Salmonella spp. and B. cereus in pasteurised milk is shown in Figures 
3.12 and 3.13. 
Table 3.16 Mean estimated concentration of microbiological hazards in milk 
immediately after pasteurisation (assuming no further contamination) and the mean 
volume of milk required to encounter 1 cell 
Hazard Mean Concentration Equivalent Volume 
(cells/L) (litres) 
E.coli <10-'" >lO'u 
Salmonella spp 10-9 109 
L. monocytogenes <10-14 >1010 
Y. enterocolitica <10-14 >1010 
C.jejuni <10-14 >1010 
B. cereus 2 0.5 
S.aureus <10-14 >1010 
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Figure 3.12: Mean estimated concentration of Salmonella spp. in pasteurised liquid 
milk. (X-axis values are in log10 scale. Vertical delimiters demote the 51h and 951h 
percentiles) 
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Figure 3.13: Mean estimated concentration of Bacillus cereus in pasteurised liquid 
milk. (X-axis values are in log 10 scale. Vertical delimjters demote the 51h and 951h 
percentiles) 
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4. Discussion 
4.1 Assumptions and Methods 
There are two types of assumptions listed in the description of the model (section 
2.5), critical and non-critical. A critical assumption is one that affects the estimates of 
hazard concentration and/or frequency sufficiently to have a bearing on the final 
interpretation. Conversely, a non-critical assumption is one that affects neither the 
estimated concentration, nor frequency, of hazards present in milk, or perhaps does but 
only in a trivial sense. That is, the criticality of each assumptions listed are based on the 
effect they have on estimated food safety risks. Assumptions are used to simplify the 
modelling of a complex system. 'Parsimony' is considered of importance in modelling, 
the fewer the assumptions used in a model the greater the parsimony. 
Farm level Module 
The assumption that there is no seasonal variation in milk production is incorrect. 
However, this assumption is non-critical because it does not relate to annual food safety 
risks, only to milk production. If it were demonstrated that seasonal milk production 
affected the likelihood and severity of hazard contamination, the model would need to be 
updated to account for seasonal variation. Related to this is the assumption that all cows 
produce the same mean volume of milk per day. This assumption has three parts; that 
the daily milk production is not related to status with respect to the occurrence of 
pathogen, the breed of the cows, nor related to herd size. These are again non-critical 
assumptions, and are not related to estimation of food safety risks. The final non-critical 
assumption listed for this section of the model is the spatial distribution of hazards in the 
farm milk vat. It is assumed that they are evenly distributed, that is, there is no clumping 
of bacterial cells and there are no "hot spots" for chemical hazards. 
Three farm sizes were used as inputs in the model. These three class sizes were 
chosen on an arbitrary basis as the range of farm sizes in NSW scaled from 10 to over 
20000 cows. A simple method was required to cover most of this range, and produce as 
similar proportion of farms in each of the appropriate classes. Hence a distribution for 
the actual farm sizes was not used, as this produced too many 'large' farms and too few 
'medium' farms. An alternative method was considered using a Uniform distribution 
between 0 and 1. If the value sampled from that distribution was within any particular 
range (accounted for by the 'large', 'medium' and 'small' classes), then the number of 
cows on that farm would follow the distribution for cow umber as used in the model. 
Regardless, the approach used allows the user to quickly gauge the number of farms in 
each class (using a sum function in Excel). 
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The potential growth of pathogenic bacteria in the farm milk vat would be affected 
by the assumptions regarding the constant temperature of the farm milk vat, the lack of a 
lag phase for contaminating organisms and similar growth phase for the contaminating 
bacteria. The constant temperature in each farm milk vat is considered as the average 
temperature of the milk in that vat prior to collection by the milk tanker. Growth 
predictions from this mean temperature are similar to those obtained through the 
integration of all time temperature intervals provided that the temperature does not 
fluctuate greater than ,...,5°c (Ross, 1999). Assuming lack of a lag phase for the 
contaminating pathogenic bacteria simplifies the module. It has been observed that the 
lag is inversely proportional to the maximum specific growth rate, at a given temperature; 
however, these effects have not been modelled (Smith, 1985; Mackey and Kerridge, 
1988; Baranyi and Roberts, 1994). Similarly, by taking all cells present for each 
pathogen as being in the same growth phase, the complexity of the module is reduced 
(Baranyi and Roberts, 1994). These assumptions are critical, and investigation into their 
effects on the risk estimate is warranted. Investigation into the time taken to resolve the 
lag phase in several bacteria including; Listeria monocytogenes, E. coli, S. aureus, 
Salmonella spp., C. perfringens and B, stearothermophilus, has been undertaken (Ross, 
1999). The two remaining assumptions listed for this module are simplifications of the 
potential contamination events and the magnitude of those events: critical assumptions, 
for which no published information to assess their validity are available. Any cow will 
have some degree of contamination on the udder even with sanitation and washing of the 
udder. It is not possible, however, to determine precisely the distribution for the possible 
numbers of contaminating bacteria from the published literature (most likely because 
this quantity would be difficult to measure). It is possible to interpolate the likely 
contaminants of raw milk from farm microbiological test results, but a better solution 
would be to conduct research to determine the type of bacteria present as udder 
contaminants, the extent of contamination within the herd and on individual udders and 
the magnitude of that contamination. A prelude to such research would be to determine 
if suitable measurement systems exist.for procuring the desired data. 
The constant value used to estimate the degree of contamination of raw milk from 
the udders of contaminated cattle is an assumption that is subject to error. For example: 
a cow may be infected with a high level of Salmonellae. This could induce a high rate of 
voiding of soft faeces, which may lead to an increase in the numbers of Salmonellae 
present on the cow's udder. Due to a higher amount of bacterial contamination of the 
udder more Salmonella could enter the milk. Also, Listeria monocytogenes is 
recognised as a cause of mastitis in cows (Varnam and Evans, 1991), and could lead to 
an increase in the level of this organism being shed into the milk though the udder. 
There may be other influences on the probability of the udder being contaminated, 
including: environmental conditions, the geography surrounding the farm and the region, 
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the health status of the cow, the time of year etc. There is no published information 
about the relationship between these factors. Including them into the model increases the 
complexity of the model without necessarily improving the accuracy of the predictions. 
Milk Collection and Transport Module 
The assumptions in this module are all related to hazards,· and hence they are 
potentially 'critical'. One example is the assumption that no time elapsed between the 
first milk collection and the last. This removes the complicating factor of .having 
different populations of bacterial pathogens in different growth phases within each 
tanker. That is, the average time and temperature is used to determine the growth in the 
farm milk vat and the tankers. By taking into account travelling times of bulk milk 
tankers between farms, the model reflects reality but a layer of complexity is added to the 
model. In the end this complexity" was judged unnecessary because, although it may be 
a reason why bacterial counts could increase, the amount of time usually involved is 
quite small (range about 0.5 to 3 hours) and unlikely to be sufficient to result in growth. 
Further consideration of inclusion of this factor in the model would require evidence 
from a study evaluating the importance of bacterial growth in bulk milk tankers in the 
'between pick up interval'. This assumption is linked to another assumption, that of the 
milk in the tanker being at a constant temperature despite several intakes from different 
farm vats and the inevitable variation induced by the performance of refrigeration 
systems. Milk collected from each farm would realistically be at different temperatures, 
however, it is assumed that the dilution effect from multiple farm milks entering the 
tanker evens out the temperature to a constant, thus simplifying the integration of 
potential growth from multiple temperatures (Ross, 1999). 
It is assumed that all hazards present in the farm milk vat are transferred to the 
milk tanker without loss. That is, there are no residual hazards present in the farm milk 
vat before the next day (iteration). Milk vats are not cleaned on a daily basis, and the 
actual mechanisms for hazard transfer between the milk vat and the milk tanker are not 
properly understood. There is likely to be a residual level of hazard in the farm milk vat 
after collection, but this residual amount is an unknown value. The assumption that the 
milk in the farm milk vat is at a constant temperature throughout the entire volume is a 
simplification of the minor temperature variations between different regions within the 
milk vat (Alavi et al, 2001). These temperature variations may or may not be significant 
to the growth of the bacteria present in the vat. 
Until the point in the model when the tankers deliver milk to the processing 
factory and the milk is mixed further, each tanker is considered separately. The 
importance of this is that it allows us to make predictions about the potential bacteria 
growth in each tanker. There may be tankers that do not have any pathogens in them 
and others with large amounts. 
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Factory Module 
The three assumptions used in this module are similar to three of those in the 
above module, i.e. no time lapse between the first milk delivering milk to the factory and 
the last, hence precluding the possibility of microbial growth. The average time and 
temperature between the farm and factory is used to calculate growth potential of 
microbial hazards that may be present. The hazards present in the raw milk entering the 
factory silo are distributed evenly throughout the volume of milk in the silo. All hazards 
are transferred from the milk tanker to the silo without loss; hence there are no hazards 
present in the tankers between days (iterations). 
Pasteurisation Module 
It is assumed that vegetative bacterial cells present in the milk as it is pasteurised 
are inactivated according to log-linear th,ermal kinetics. This assumption is a 
simplification of the true thermal inactivation kinetics, and will be discussed more fully 
later (section 4.3). Chemical hazards ~re assumed to be unaffected by the time or 
temperature of pasteurisation, hence, only dilution is considered in the model. At this 
stage there are no concentration steps considered during processing. Minor fluctuations 
in the time and temperature of each litre pasteurised are not accounted for in the model. 
It is simply assumed that for each given pasteuriser the time and temperature is constant 
for that day (iteration), however, between different pasteurisers and between 
pasteurisation runs different time/temperature combinations are modelled. There is a 
lack of published information regarding the thermal inactivation of vegetative cells of 
Bacillus cereus. Hence it is assumed that prior to pasteurisation, the vegetative cells have 
sporulated and are unlikely to be inactivated by pasteurisation. 
4.2 Hazard identification 
The ranking of hazards into the 4 groups (see table 1.10) is arbitrary. Those 
hazards listed are a subset of the potential hazards that may be found in liquid milk (van 
Gerwen, 2000) including chemical hazards. Some of the hazards (Aflatoxins, 
Enterococci and mycotoxins) that were highlighted for investigation were considered of 
importance by the dairy industry representatives simply because there is a lack of data 
concerning them. The nature of the work undertaken did not generate new data about 
these poorly understood hazards rather it involved a systematic synthesis of the existing 
published information about the hazards listed, where that information that was available, 
to produce the risk assessment model. That is not to say that these hazards should be 
excluded from investigation, but that the published information about these hazards was 
insufficient to include them into the risk assessment model. Further investigation into 
the following hazards would be of benefit in determining their food safety risk for the 
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dairy industry: antibiotic resistant Enterococci, aflatoxins, Cryptosporidiwn spp, 
mycotoxins, Toxoplasmosis gondii, Clostridium spp, and viral hazards. The required 
information for these hazards includes the frequency and severity of contamination of 
milk at the farm level, growth potential, the effect of pasteurisation on these hazards and 
potential adverse health effects from the ingestion of these hazards through dairy 
products. 
4.3 Thermal inactivation of bacterial pathogens 
It is assumed that the thermal inactivation of bacterial pathogens present in raw 
milk follows log-linear kinetics. For several organisms, e.g. E.coli 0157:H7, Yersinia 
enterocolitica, and Salmonella Enteritidis this has been shown to be invalid in at least 
some situations (Toora et al, 1992; Humpheson et al, 1997; Juneja et al, 1998; Huang 
and Juneja, 2001). The conditions used to simulate pasteurisation conditions in the 
model are a temperature range between 74°C and 78°C for a duration of 15 to 20 
seconds. The experimental conditions for which the non-log-linear thermal inactivation 
kinetics have been reported were 55 to 63°C for 60 to 4500 seconds. Firstly, the 
temperatures used to demonstrate non-log-linear thermal kinetics are lower than those 
used in pasteurisation. Secondly, the time of exposure to the elevated temperature is 
between 3 and 300 times longer than those used in HTST (high temperature short time) 
pasteurisation. Examination of the experimental data shows that for the initial 20 
seconds log-linear inactivation kinetics are displayed, regardless of temperature (Toora et 
al, 1992; Humpheson et al, 1997). This indicates that for HTST pasteurisation, the 
assumption of log-linear inactivation kinetics appears to be valid. However, if a lower 
temperature and longer time were used to pasteurise milk, as with batch pasteurisation, 
biphasic inactivation (initial rapid reduction in cell numbers followed by a more gradual 
decrease) might be observed (Toora et al, 1992; Humpheson et al, 1997; Juneja et al, 
1998). The model developed in this risk assessment assumes that HTST pasteurisation 
is used. Milder heat treatments that demonstrate non-log-linear thermal inactivation are 
unlikely to be used in the processing of raw milk (Geeraerd et al, 2000; Chandler pers 
comm., 2002). 
With the exception of Bacillus stearothermophilus and B. cereus spores 
' (Fernandez et al, 1999; Leontidis et al, 1999), published reports on thermal inactivation 
kinetics have dealt with temperatures below 70°C. The model describes pasteurisation 
temperatures exceeding 70°C, thus it has. been assumed that log-linear thermal 
inactivation kinetics holds up to 78°C. The difference between the experimental 
temperatures used and those used in the model can be reconciled. At 60°C the D value, 
in seconds, for Salmonella Enteritidis PT4 is 13.2. This is the maximum temperature 
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within the limits of the data set (Humpheson et al, 1998). From the model the upper 
confidence interval of the mean estimated concentration of Salmonella spp. is 0.156 
cells/L (l.56 x 10-4 cfu/ml), hence even if pasteurisation were at the lower, 60°C, 
temperature, survival would be negligible: in the order of 1 cell per 10 OOO litres of milk. 
The method to estimate the parameters of the log-linear thermal inactivation 
models used surrogate data in some cases as a source of data for the bacterial pathogen 
being modelled. In some cases there was no specific data for inactivation in liquid milk. 
For these organisms the pooled data from thermal inactivation studies were used (section 
3.3). Most notable are the variations in thermal tolerance in strains of Salmonella spp 
(Humpheson et al, 1998; Veeramuthu et al, 1998; Smith et al, 2001). There appears to 
be two different inactivation curves (Fig 3.1.2.4), giving a poor fit to the single log-linear 
regression line. However, re-examination of the data did not show that the data set was 
derived from two distinct groups of data and that S. senftenberg was not included in the 
dataset, S. senftenberg has a higher thermal tolerance than other Salmonella spp 
(Murphy et al, 1999). The situation is reversed for Listeria spp, with statistically non-
significant differences in the thermal inactivation in milk between three species (L. 
ivanovii, L. seeligeri and L. welshimeri) and three strains of L. monocytogenes 
(Bradshaw et al, 1991). Differences in the thermal kinetics are also evident upon 
examination of data derived from different food types or laboratory media (Mackey and 
Bratchell, 1989; Juneja et al, 1997). Estimates using broth systems with a similar pH 
and water activity to milk provide an adequate means to describe the thermal inactivation 
kinetics of some bacteria; however, in plant measurements or those with milk as the 
medium for investigation are by far the best means to estimate the true thermal 
inactivation kinetics (D'Aoust et al, 1988). 
4.4 Consumption patterns 
Australians consume between 250 and 500 grams of dairy products daily with· the 
major components being liquid milk, yoghurt and cheese. There is good agreement 
between the consumption figures for both the Australian Bureau of Statistics (ABS) 
survey data and the Australian Dairy Corporation (ADC) and Dairy Research and 
Development Corporation (DRDC) consumption data, however, there are some critical 
data gaps in the production figures collected from the ADC. The consumption data 
presented from the ABS survey matches closely the production and consumption figures 
from the DRDC and ADC for the 1995/96 financial year, however, as the annual raw 
milk production in Australia has increased from 8206 million litres to 10179 million 
litres in the past 5 years it is necessary to extrapolate the consumption figures to reflect 
the change in productiqn volumes. Similarly the Australian population has risen from 
""17million to ""19million, with a difference in age structure, i.e. a greater number of 
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people aged 65 and over. When calculating the exposure to hazard of an individual it is 
necessary to take the changes in age structure of the population into account. For the 
majority of dairy products there are more recent production figures, moreover it is 
possible to reduce the uncertainty of extrapolating from this data through the acquisition 
of further ABS nutritional survey data and further collection of Australian dairy 
production statistics. 
4.5 Model implementation and estimates 
The farm level module is potentially critical in determining the food safety risk 
associated with dairy production. This is because many different contamination events 
and types of hazard occur at this module. Hence accurately modelling this aspect of the 
production process is pivotal in determining the food safety risks associated with dairy 
products. Some of the estimated input parameter distributions do not accurately reflect 
the true contamination at the farm level, as can been seen with the modelled and observed 
contamination of milk by antibiotics (see section 3.8). 
The level of contamination with microbiological hazards from individual cows was 
set as a constant (see section 3.5). It is not know if there is a variable magnitude in 
contamination or not, however, it seems likely that this is the case. Listeria 
monocytogenes is recognised as a cause of mastitis in cattle (Vamam and Evans, 1991). 
Sub clinically infected cows are likely to shed this organism into the milk at higher 
concentrations than those that are not infected, thus an increased load in milk of this 
organism may be expected from a herd with infected cattle. The USDA/FDA (2001) 
risk assessment for Listeria monocyto genes in ready to eat foods revealed that this 
organism's presence in pasteurised milk ranked it as the second highest source of 
exposure. The large volumes of milk consumed in the USA and the relatively low 
exposure per volume gives a small risk of infection per serving. However, in the event of 
a pasteurisation failure, the widespread consumption of this product poses a far greater 
risk of infection and illness from Listeria monocytogenes. In Australia, where milk 
production practices are comparable, the situation is likely to be similar. Therefore it is 
important to elucidate the magnitude of contamination of raw milk at the farm level with 
L. monocytogenes to determine the risk from this organism through the consumption of 
dairy products, however, post-pasteurisation contamination is of more concern. 
Potentially Y. enterocolitica is an organism that may be of concern for the dairy 
industry. The growth model used for this organism allowed growth at low temperatures. 
However this is not necessarily an indication of this organism's potential threat to 
health. There are no dose response models developed for this organism, and its 
incidence in Australia is less than 8 cases per million people annually, with no reported 
foodborrte infections between 1980 and 1995 (CDN, 2000). It is readily inactivated 
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through pasteurisation, although it may survive if present in high concentrations (108 
cfu/ml) before pasteurisation (Toora et al, 1991). There is little emphasis laid upon this 
organism in Australia's dairy industry, however this is not surprising given its low status 
as a disease causing organism in this country (CDN, 2000). The model estimates 
indicate that Campylobacter is an organism that has little impact in the dairy 
environment. It lacks the necessary ability to grow at low temperatures for it to be of 
major concern, however it is recognised as having significant disease causing potential in 
other products, such as poultry (Altekruse et al, 1999). 
The mean growth rate was used to model potential increases of pathogenic 
organisms in milk. However, using the upper confidence interval for growth rate 
estimates did not dramatically increase the likelihood of pathogen surviving 
pasteurisation (data not shown). Even using an unrealistic increase in growth rate 
(IOOtimes faster) would not impact on the survival of pathogen post-pasteurisation, 
however, it would be of importance if adherence to regulatory guidelines for 
pasteurisation conditions were not met. However, this would be the case even with lower 
than average growth rates, thus pasteurisation is of vital importance for milk prior to 
consumption . 
In terms of trade, antibiotic and pesticide residues are an important issue. The 
model does not predict any failures to meet Australian regulatory standards for the 
MRL. However, recent surveys conducted by dairy authorities in Australia (ADASC, 
2001; DFSV, 2001) show that there are some antimicrobial residues detected in factory 
silos (0.04% positive). The model estimate for antibiotic concentration in the factory 
silo and the percentage of tests positive for the presence of antibiotics found in the 
survey are not in agreement with these observations. There are a number of possible 
explanations or causes for this discrepancy: no particular antibiotic is specified in the 
survey, hence the MRL is also unknown, the concentration of the positive samples from 
the survey is not specified, in the model the level of contamination arising from each 
contaminated cow in the farm module is an estimate as the actual contamination level is 
unknown. There is a lack of information regarding the magnitude of contamination per 
cow at the farm level for antibiotics and pesticides. This is an important issue and 
further investigation is warranted. The rationale behind the inclusion of chemical 
contaminants in the risk assessment was two-fold. Firstly, to complete the assessment 
as much as possible by including further food safety hazards. Second, to highlight the 
ability of the modelling approach to accurately model the effects of the addition of these 
types of hazards in the assessment. 
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4.6 Further A venues for Research 
Construction of the model revealed several new aspects of the dairy industry that 
could be further investigated to improve predictions of risk. Each of the required areas 
is discussed. 
Pasteurisation was another important issue in the overall development and 
implementation of the model. A key aspect of the outputs from the model is the 
importance of the widespread use of pasteurisation as a means to reduce microbial 
hazards to low levels. Current regulatory practice in Australia provides a safety margin 
of greater than 1000 fold; however, it was not possible with the data available to 
determine the frequency or occurrence of pasteurisation failure. Data concerning this 
would provide an interesting avenue of research into the importance of pasteurisation. 
Coupled with the use of an appropriate stochastic model the effects of pasteurisation 
failure on the risk from microbial pathogens in liquid milk could be determined. Also 
the level at which microbial pathogens become a concern may also be elucidated, thus 
giving insight as to the necessity of pasteurisation for these hazards. 
The single largest gap in data that prevents the successful completion of the risk 
assessment model is the effects of post pasteurisation contamination on the hazard 
concentration in the milk. It is known that pasteurisation is an effective means of 
reducing microbiological hazards that may be present in milk to undetectable levels 
(Toora et al, 1991). It is also known, from the NSW survey, that routine tests for 
microbiological hazards in dairy products at the factory show presence of some of those 
hazards. This implies that between the time that the milk is pasteurised and the finished 
product comes off the production line, there has been further contamination of that 
product. What is required is an evaluation of the frequency of this contamination, the 
magnitude of that contamination, and which hazards are introduced. It is possible to 
model this aspect without further data collection in .a limited way. From this basis it is 
possible to determine the frequency of contamination and the magnitude of that 
contamination from the product microbiological test results. The main obstacle in 
determining the likely frequency and magnitude of contamination with microbiological 
hazards, is that few of the potential pathogens are tested for directly and that surrogate 
organisms are used as presumptive tests for the pathogens of concern (Ingham et al, 
2000). 
The time temperature conditions to which the finished product is exposed once it 
leaves the production line is another gap in the information required to assess risks in 
the dairy products and processes. The conditions of storage, transport, and retail and 
domestic handling are important in terms of shelf life and microbiological hazard 
concentration. The range of temperatures that the product is exposed to once it leaves 
the production factory is not fully known, especially during transport, however there are 
Discussion 95 
some reports available on the temperature distribution for domestic and retail 
refrigeration (Audits International, 2000; Ross, 2002). To fully characterise the potential 
impact of these steps in the farm-to-fork continuum further research is needed. Time 
temperature data loggers provide a means to determine the storage conditions of the 
finished product once it leaves the factory. 
The final step in the formal risk assessment process is to elucidate the risk of 
contracting illness from the hazards that may be present .in the product being consumed. 
An estimate of the likely concentration of microbiological hazard in the finished product 
at the point of consumption has not been completed because of a lack of data concerning 
post-pasteurisation contamination and storage conditions between the factory and the 
consumer. There are suitable dose response models in the published literature for a 
study of this kind, together with the consumption pattern estimates by age and state, it is 
possible to construct a framework for the completion of this stage in the model. There 
are several considerations for the successful completion of the risk estimate. Both age 
and health status should be accounted for in determining the likelihood and severity of 
adverse effects to ingested hazards. Of the dose response models examined (section 
1.8) few looked at the difference in the probability of illness as a function of health 
status. Hence selection or development of appropriate dose response models is of 
importance. 
Some other areas for further investigation and data generation include: the validity 
and estimation of the inputs to the farm level module; the effects of seasonal variation on 
the concentration of hazards that may be present in milk; expansion of the model to 
cover the entire Australian dairy industry, or validation of extrapolation of the current 
model; the inclusion of non-log-linear thermal inactivation models to predict the effect of 
pasteurisation on microbiological hazards that may be present in milk, or validation of 
the models currently used to test their applicability to the Australian dairy industry. 
Other areas that could be examined include: a detailed examination of the effect of 
'between pick up' times and temperatures in the bulk milk tankers on the growth of 
microorganisms in the milk (see section 4.1); examination of the potential for growth of 
bacterial hazards in the farm milk vat prior to collection by the tanker. A clearer picture 
of the presence or absence of antibiotic residues could be gained from further study. 
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5. Conclusions 
The model estimates the concentration of seven hazards that may be present in raw 
milk arising from contamination of cows at the farm level and estimates the changes in 
concentration through collection by milk tankers (accounting for dilution and bacterial 
growth) to delivery at processing factories. The effect of pasteurisation on 
microbiological hazards that may be present is also estimated and is estimated separately 
for different production lines and pasteurisation conditions (e.g. liquid milk, cheese). 
The model can also been used as a scenarios analysis tool. By changing the inputs 
and/or distribution parameters it is possible to estimate the effect of contamination events 
at the farm level on the concentration of hazard that may be present in the factory silo. 
In this way it is also possible to model the efficacy of pasteurisation. With a model of 
this size and complexity there are problems that could not be tackled effectively in the 
time given or with the resources available. These have been highlighted in section 4.9. 
Primarily the areas that need the most attention for the successful completion of the risk 
assessment model are post-pasteurisation contamination and time-temperature 
conditions between the end of production (at the factory) and the consumption of dairy 
products (consumer). 
Notes on Modelling 
There are several points to consider regarding the attempt to model a complex 
system such as the production of dairy products in Australia. With a model of this size 
there comes a point where adding more detail becomes an onerous and difficult task. 
This extra detail may add to the "apparent reality" of the model, however the outputs 
become increasingly difficult to interpret 
The size of the model is a stumbling bock for computing power at the present 
time. Although at the time of writing the computers used to run the model are mid-to-
high end consumer level machines, there are constraints, in terms of processing power 
and memory. That is, the time taken to perform a 'run' of the model increases almost 
exponentially with the addition of new inputs and outputs. The size of the simulation 
files produced by @Risk also increases, thus requiring a greater amount of physical 
memory (RAM) in the computer, this is also related to the complexity and stability of the 
program used to simulate the model. A further consideration is the ability of the 
modelling software to cope with the complexity of the system being modelled. The 
approach used for the dairy model was such that the software was being pushed to its 
limits. 
The model has been designed for flexibility. It is with this in mind that there is a 
lack of detail in some aspects of the model, among which include: contamination events 
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at the farm level and post-pasteurisation, growth rate estimates for bacterial pathogens, 
thermal death equations, seasonal variation. The latter two aspects have been highlighted 
for the following reasons: 
• Thermal death equations - as has been mentioned previously, the thermal death 
kinetics of bacterial pathogens present in the milk is considered to be log-linear. 
This has been shown to be a poor approximation of the true kinetics for some 
organisms (Humpheson et al, 1998). This is a particularly important aspect. 
Assuming log linear kinetics there is an infinitely small probability, effectively zero, 
that bacterial pathogens survive pasteurisation, thus all contamination is due to post-
pasteurisation contamination. If on the other hand non-log-linear thermal death 
kinetics were modelled, there may be an increased chance of pathogens surviving 
pasteurisation. For a simpler overall risk assessment model, log-linear thermal death 
kinetics was chosen as the most suitable as they hold well over a broad temperature 
range. 
• The DRDC and industry partners in the project had stated from the beginning that 
they would appreciate the inclusion of seasonal variation within the model. It was 
considered that this was an additional complication on an already complicated model 
and was omitted from the initial draft of the model. Subsequently it was realised that 
it was unnecessary to include this aspect in the model simply because the required 
estimates from Summer/Spring or Winter/Autumn could be generated simply by 
altering the appropriate inputs and computing two separate 'runs' of the model. The 
effect of seasonal variation on the concentration and likely frequency of 
contamination is unknown and warrants further investigation. 
Risk assessment - A modeller's view. 
Food safety risk assessment is primarily concerned with quantifying the risk 
associated with a particular hazard being present in food and or causing illness. There 
are different ways to assess the risk of a certain event happening. The assessment may 
be either qualitative or quantitative. Moreover a quantitative assessment may be 
stochastic or deterministic, that is, the assessment may take into account variability in the 
system being modelled or it may not. 
Variability is an inherent aspect of risk assessment. There is, for example, a 
varying degree of susceptibility among humans to infection from any particular 
pathogen, the number of the organism of concern varies; the prevalence of pathogen or 
toxigenic organism is variable, and cooking procedures vary widely. To estimate the risk 
of a certain event happening it must fall between two extremes; it will never happen; or it 
will always happen. Furthermore, the chance that it will always and never happen 
changes depending on who is observing. This introduces two concepts: uncertainty and 
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risk perception. Simply by measuring an entity there are problems involved when trying 
to define exactly that measurement, the instrument may not be calibrated correctly, for 
example. Two different people looking at the same event may consider its likelihood of 
occurrence to be different. Physicists call this the Heisenburg uncertainty principle, 
which applies to measurements of the energy or position of an electron. This situation is 
analogous to two risk assessors arriving at different interpretations of the results of an 
assessment. It is not to say that either or both are wrong, but that they have arrived at 
different conclusions after considering the same event and its associated data. Despite 
these complicating factors, it is possible to produce an assessment based on the four key 
aspects of a risk assessment: the hazard - the organism or chemical of concern in the 
particular food; the exposure - the probability and magnitude of contact with the hazard; 
the dose-response - how many infectious or toxic particles are required to produce 
symptoms of disease and to what severity; and risk characterisation - integration of the 
above to produce a risk statement describing the severity and extent of disease with 
included uncertainty (Buchanan et al, 1998). These steps should be designed to be as 
objective and unambiguous as possible. 
Furthermore a model's ·effectiveness is highlighted when it fails to produce 
predicted values that are similar to known, observed values. This could be due to one of 
two causes; the inputs for the model are wrong, or the theory behind the mod~l is not a 
true reflection of reality. An old saying goes: garbage in garbage out, and is especially 
applicable to modelling. What this means is, if the inputs for a model do not reflect the 
real or observed range of values, then the model will produce a worthless or meaningless 
output. For this reason a large part of producing a model is to elucidate the range of 
possible values for each variable prior to construction of the model itself. That is, 
modelling is not a substitute for research that involves the collection of data, but should 
be complementary. A risk assessment is the culmination of a long series of collected 
data put into a structured form to produce meaningful results and interpolations to 
correct that data within a conceptual model. 
The question arises "Why model?" The short answer, simply, is to predict, but 
this is not the sole purpose. Baird-Parker and Kilsby (1987) recognised that being able 
to describe microbial systems in unambiguous equations is a true sign of predictive 
modelling. With knowledge of a few key parameters it should be possible to predict 
what will happen to a microbial community over time. With an even greater 
understanding it is possible for risk assessment as a science to develop into something 
that is reliable and wholly inclusive; a state, which at the present time, it has not reached. 
The assessment process is capable of identifying the research needs for the situation 
being considered and useful for defining the current state of knowledge about that 
situation. 
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Computer specifications used for running the model 
Primary system: 
Gateway Select 700 
- Athlon 700 Mhz 
15 Gb HD 
128MbRAM 
Secondary portable system 
- Dell Latitude 
- Pentium 4 l .6Ghz 
18.5 Gb HD 
512MbRAM 
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Appendix A. NSW Dairy Industry Survey 
SafeFood NSW I Dairy Research and Development Corporation 
NSW Dairy Industry Risk Assessment 
SafeFood NSW is undertaking a risk assessment project covering the entire NSW dairy 
industry, .In order to better target the risks associated with dairy products produced 
within the state. This project will ensure efficient risk minimisation strategies can be 
developed, and is occurring as part of a much larger National Dairy Industry Risk 
Assessment Project being funded by the Dairy Research and Development Corporation. 
Attached is a proforma consisting of 6 sections, which has been sent out to every milk 
processing and dairy product manufacturing f~ctory within the state. The completion of 
this form will assist SafeFood NSW in gaining the necessary data to properly conduct 
the risk assessment. Your cooperation is greatly appreciated with providing this 
information, which will lead to a much more scientifically robust assessment. 
The proforma has been designed so that it is simple to complete and will take up very 
little of your time. However, if you are able to provide more detailed information, such as 
individual herd sizes, milk transport logistics, it would enhance the accuracy of the 
project 
This data provided by industry will be used to form the most comprehensive risk 
assessment of the Australian Dairy industry to date. The first draft of the NSW project 
report is due in October, with the final report on the NSW element of the risk 
assessment due to be completed by the end of the year. 
All results will be treated in the strictest confidence. 
All returns are to be completed by 30rh July and returned in the prepaid envelope to 
Attention: David Miles 
SafeFood NSW 
PO BoxA2613 
Sydney South 1235 
Thank you for your co-operation 
Terry Outtrim 
Executive Director - Dairy 
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SafeFood NSW I DRDC Dairy Industry Risk Assessment 
(Please complete the sections applicable to your business) 
Section 1 MILK AND DAIRY PRODUCTS 
What products does your factory produce, and approximately what is the 
annual production volume? 
D Pasteurised Liquid Milk Products ..................... volume: ................... L 
D Cheese ....................................................... volume: .................. kg 
D Cheese with moisture >40%, pH>5.0 ............... volume: .................. kg 
0 Yoghurt and cultured dairy products ................ volume: .................. kg 
0 Milk powder. .............................................. volume: .............. tonnes 
0 Cream ...................................................... volume: .................. kg 
0 Refrigerated Ice Cream Mixes (eg soft serve) ...... volume: ................... L 
0 Frozen Ice Cream and related products ............. volume: .................. L 
0 Dairy Desserts/ Dips ...................................... volume: .................. kg 
0 Sweetened Condensed Milk ........................... volume: ................... L 
0 Butter. ........................................................ volume: .................. kg 
0 Kash ta ......................................................... volume: ................. kg 
Other (please specify) .......................................................................... . 
Section 2 FARM MILK PICKUP 
What is the number of farms supplying milk to your factory? 
D Milk supplied from another factory (go to Section 3) 
D 1-20 
0 20-40 
0 40-60 
0 
0 
0 
What is the average herd size of the farms supplying your factory? 
0 1-40 0 
0 100-250 0 
0 500-800 0 
60-80 
80-100 
>100 
40-100 
250-500 
>800 
What is the compliance rate for farm milk temperature? (ie less than 4 °C at pickup) 
0 95-100% 0 90-95% 
0 80-90% 0 less than 80% 
What is the maximum temperature that milk is regularly picked up at ......... °C 
Section 3 MILK INTAKE 
What is the annual milk intake for your factory (in litres)? ............................ L 
What is the storage temperature when delivered to the factory? 
Minimum ................ °C Maximum ............... °C Average ............... °C 
What is the age of the milk when it is pasteurised? 
Minimum .............. hrs.. Maximum .............. hrs. Average .............. hrs. 
D pasteurised milk delivered - Go to Section 5 
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Section 4 PASTEURISATION 
How may pasteurisers do you operate within your factory? 
Batch...................................... HTST .................................... : 
For each pasteuriser, please complete the following table. Where a pasteuriser is used 
for several different products, please list each set of time/temp conditions 
Pasteuriser Normal operating Diversion valve set Holding time 
temperature (°C) temperature (°C) (sees) 
1 
2 
3 
4 
Section 5 TRANSFER OF MILK 
Do you also send milk I cream I skim I concentrate to other factories? 
0 NO - Go to Section 6 0 YES 
If Yes, which products and what annual volume? 
D 
D 
D 
Raw milk ................... L 0 Pasteurised milk ..................... L 
Raw cream ................. L 0 Pasteurised Cream .................. L 
Other ( eg skim concentrate) ......................................................... . 
How many factories do you send product to? ............................................ . 
Do you send product interstate? Where? ................................................... . 
Section 6 MICROBIOLOGICAL TESTING 
End product testing 
What type of end product testing program do you have in place? 
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List the number of final product failures that have occurred in the last 2 years 
Date Product Reason Volume 
(month/year) involved 
Environmental sampling 
Do you conduct a regular environmental microbiological sampling plan? 
0 NO 0 YES 
If Yes, how often do you detect high levels of bacteria from environmental swabbing? 
From what environment do you most often detect high levels of bacteria? 
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Appendix B Profile of the Australian population's health 
A report submitted to the Dairy Research and Development Corporation as part of 
contractual obligations for the completion of the project "Food Safety Risk Assessment 
for the Australian Dairy Industry". 
Written by Dr. Tom Ross (2001) 
Australian Susceptible Populations 
Some food-borne diseases are more likely to affect members of the population 
with specific medical conditions, or of certain ages. The probability of acquiring 
infectious disease in particular is affected by immune system function. For example, 
epidemiological data infers that susceptibility to listeriosis varies enormously, with those 
with the most compromised immune systems, e.g. AIDS patients, transplants recipients 
or other on immune-suppressive therapy, much more likely to become ill. Similarly, 
very young infants do not have fully developed immune responses, and immune function 
in human adults decreases with age. Also, the developing foetus is at increased risk 
from a range of chemical contaminants. In this section is described the age structure and 
health status of the Australian population to better characterise risks of food-borne 
disease, in particular the risks to groups of known increased susceptibility. 
Age and Gender Structure 
The age structure of the Australian population is described by data from the 
Australian Bureau of Statistics (ABS, 2001) and Australian Institute of Health and 
Welfare (AIHW, 2001) and is shown in Figure 1 below. Since the turn of the century 
the population at all ages has grown significantly, but it has also aged as a whole. 
Australians have been having smaller families, so there has been a fall in the proportion 
of children. In particular, the proportion of the population aged 65 and over has 
increased markedly and in 1998 had reached 12%. The very young, at increased risk of 
a range of infectious diseases, comprise about 5% of the population. 
Numerical estimates of the percentage of the population in various age and gender 
groups.1999 are shown in Table 1. 
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Table 1. Age/gender structure of the Australian population as at 30 June 
1999 (after AIHW, 2001 ). 
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Figure 1. Comparison of then age-gender structure of the Australian population 
by age and gender in 1901 & 1998 (ABS, 2000). 
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Health Status 
The prevalence among the Australian population of a number of diseases follows 
the pattern seen in Figure 2. Included are cancer, diabetes, chronic obstructive 
pulmonary disease, acute respiratory disease and osteoporosis and osteoarthritis. Some 
of these conditions predispose to other illness. In addition, for some disease there is an 
age based peak of prevalence among the very young that declines rapidly with the first 
few years of life. Hence , the very young, and older adults (from about age 55), are 
recognised as being at increased risk of food-borne infectious disease. 
Conditions known to affect immune status include HIV/AIDS, cancers and organ-
transplants (due to the use of immunosuppressive drugs and therapies and to 
immnosuppression caused by the cancerous cells· directly), those with liver and kidney 
disease, alcoholism, diabetes and pregnancy. In addition, some toxins, e.g. methyl 
mercury, benzimidazole used in antihelminthics, are known to pose a greater hazard to 
developing foetuses. Some data are available that describe the levels of these diseases 
and conditions among members of the Australian population. 
Organ Transplant Recipients 
Functional renal transplant recipients are reported to be 25 per 100,000 Australian 
population (AIHW, 2000) with the number rising at the rate of an additional 1 person 
per 100,000 per year. The increase in the number of people with functional transplants is 
due mainly to marked improvement in the survival of kidney transplants. Of people who 
had a cadaveric kidney transplant in 1983, 58% had a functioning transplant 5 years 
later, increasing to 73% of those who had a transplant in 1993 (Disney et al., 1998b, 
1999). There are approximately 500 transplants performed per year. Consequently, the 
rate for functioning kidney transplants has increased, from 9 per 100,000 in 1979 to 25 
per 100,000 in 1998. There were 517 kidney transplant operations in 1998. In Australia 
in 1997/8 in public hospitals there were 139 liver transplants (11 % died, 85% went 
home); 79 lung transplants (11 % died, 87% went home); 23 multiple organ transplants 
(4% died, 91 % went home); 73 heart transplants(~% died, 92% went home) (TR: GEf 
REF) .. We have not yet found survival data for these other transplants. If we assume the 
same relationship between annual rates of transplants and survivors in the community, 
we estimate an additional 2600 organ transplants recipients in Australia. 
HIV/AIDS 
At the end of 1998, there were around 11,800 people living with HIV. By then, the 
cumulative number of HIV infections in Australia was estimated to be about 17 ,600. A 
total of 2,430 persons were estimated to be living with AIDS in 1998 (NCHECR, 1999). 
The majority of cases are males aged between 30 and 44 years (AIHW, 2000). 
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Cancers (excluding non-melanoma) 
Cancerous cells may suppress or damage the immune system. Each year, 
approximately 345,000 new cancer cases are diagnosed in Australia. A large proportion 
of these, approximately 270,000, are non-melanocytic skin cancers (NMSC) which, if 
treated early, are far less life-threatening than most other cancers. Discounting these 
leaves 75,000 new cancer cases per year. Mortality data is also available but prevalence 
data, required to assess the number of Australians more susceptible to food-borne 
illnesses, is less readily available, as commented on by SACR (1999). 
SACR (1999) surveyed South Australians for the prevalence of different types of 
cancers, and presented gender and age-separated prevalence data. The probability of 
diagnosis of cancer increases markedly with age (see Figure 2, below). Crude estimates 
(i.e. across all cancers and ages) were 1475 and 1369 (age-standardised) cases per 
100,000 population for males and females respectively. 
The mean prevalence per 100,000 males and females of cancer cases diagnosed within 
10 years varied by index day and age, is shown in Table 2, below: 
Age Group 
Cases/100000 
c: 
0 
·.;::; 1500 RS 
:::s 
c. 
0 
c. 
0 
0 
0 1000 0 
0 
.-! 
:i... 
QI 
c. 
Ill QI 
Ill 
5000 RS u 
:i... 
QI 
u 
c: 
RS 
u 
Table 2. Prevalence of Cancer by Age (SACR, 1999) 
0-9 
63.2 
10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ 
106.6 262.3 657 1 1494.2 2933.2 59503 9565.8 12127.2 
o'------~-~ 
0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ 
Age Group 
Figure 2. Cases of cancer (non-melanoma) per 100,000 Australians by Age 
We have been unable to locate equivalent Australia-wide data, nor the proportion 
of those cases undergoing active treatment that would reduce immunity. 
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Kidney Disease, Dialysis and Liver Disease 
About 28 per 100,000 Australians require dialysis (AIHW, 2000) with the number 
rising at the rate of an additional 1 person per 100,000 per year. The increase in the 
number of people on dialysis is mainly due to older patients being accepted on the 
program. In 1998, 38% of new patients were aged 65 years and over compared with 7% 
in 1979 (Disney et al., 1999). Stagnancy in the availability of new donor or cadaver 
kidneys during the 1990s has also contributed to the increase in dialysis patients 
(Disney et al., 1999). 
The prevalence of cirrhosis and other chronic liver disease was estimated at about 
70 per 100,000 males and 50 per 100,000 females (Mathers et al., 1999). Cases are 
concentrated among those aged 35 years and over. 
Diabetes 
Diabetes is a long-term (chronic) condition in which blood glucose levels remain 
high because the body produces little or no insulin or cannot use insulin properly. 
Diabetes also contributes to many pregnancy-related complications for the mother and 
the unborn child. 
There are no consistent national estimates of the prevalence of diabetes. According 
to the 1995 National Health Survey (ABS, 1997), over 430,700 Australians (2.4%) 
reported that they had been diagnosed with diabetes at some point in their lives. Of 
those, 82% reported that they currently have diabetes (ABS 1997). The true prevalence 
of diabetes is considered to be higher than the figures given above suggest because a 
large proportion of diabetes, especially Type 2 diabetes, remains undiagnosed in the 
community. It has been estimated that for every person in the population diagnosed with 
diabetes, there is one undiagnosed person (DHAC, 1999). It is therefore estimated that 
there were about 700,000 people with diabetes in Australia in 1995 (Amos et al., 1997). 
The prevalence of diabetes increases with age, from 0.1 % among people aged less 
than 15 years to 8.9% among those aged 75 years and over (ABS, 1997). 
Alcohol Dependency 
There are no data available that directly indicate the incidence of alcohol-related 
physical health debilitation in the Australian community (Grant and Petrie, 2001). 
Nonetheless, some data are available which enable crude estimates to be made. 
"Hospital separations" data describe the conclusion of a stay in hospital by a single 
patient1• and can be used to gauge the level of morbidity due to a particular condition in 
the community (AIHW, 2000). Hospital stays where alcohol dependence was the 
primary reason were approximately 9900 for men and 4700 for women in 1997-98 in 
Australia. Of those hospital stays, there was a strong age-dependence with prevalence 
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peaking in people of age 45 -54. Similarly, a single day survey of clients at alcohol and 
drug dependency treatment services (which achieved 92% coverage across Australia) 
reported that 2570 Australians were treated. In the National Drug Strategy Household 
Survey 1 % of (""5,000) males reported attending an alcohol treatment program, though 
whether this was for physical health reasons is not disclosed. Based on these data we 
estimate the level of Australians to be severely debilitated through alcohol dependency to 
be of the order of 0.1 %. 
Pregnancy 
ABS (2001) reports 249300 births in Australia in 1998, in a population then of 
188718002• In 2001, the population is expected to be closer to 19300000. Accordingly, 
but ignoring the slowly declining birth rate, 257600 births would be expected. Further, 
ignoring multiple births, and because each pregnancy only lasts 9 months, the number of 
Australian women pregnant at any one time is expected to be "" 193,200 (or 0.99% of 
the total population) in 2001. 
Thus, the proportion of Australian women that are pregnant at any given time is 
""2%. This is consistent with the figure of 1.7% for USA presented in CAST (1994). 
Conclusions 
From the data presented in above it is evident that the likelihood of an individual 
being in many of the susceptibility classes increases with age. As noted by Hitchins 
(1996) it is highly likely that the inclusion of both age persons and those with cancer or 
diabetes would lead to 'double-counting' of the prevalence of susceptible populations 
within the Australian community. Conversely, even without underlying disease such as 
cancer or diabetes, elderly Australian are still more susceptible to infectious disease 
because their immune system 'weakens' with age. 
Table 3 below summarises the data for the percentage of the population in various 
categories of increased susceptibility to food-borne illness. 
1 If the same patient re-enters the hospital that is considered a separate case. It is possible, thus, that 
some separations involve the same patient many times. 
2 We note that from Figure 1 can be inferred that there are -245,000 births per annum. 
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Table 3. Estimate of the proportion of the Australian population at 
increased risk of food-borne illness. 
Age > 65 years 
Age > 60 years 
Age< 30 days 
Organ Transplant Recipients 
HIV 
AIDS 
Cancers (non-melanoma) 
Kidney 
Other 
(Leukaemia - 3% of all cases) 
Pregnancy 
Kidney Disease, Dialysis 
Cirrhosis, Chrome Liver Disease 
Diabetes 
Alcohol Dependency 
TOTAL (includmg age >60 years) 
TOTAL (includmg age >65 years) 
10.16 
13.70 
0.25 
0.03 
0.01 
0.10 
0.01 
1.42 
0.99 
0.03 
0.12 
1.97 
0.10 
18.7 
15.2 
The data shown in Table 3 are generally consistent with estimates made for other 
nations, e.g. G. Paoli (pers. comm., 1999) estimated the susceptible population to be 
17% using North American data. Lindqvist and Westoo (2001) derived an estimate of 
20.1 % for Sweden (including the population> 65 years old) while Buchanan et al. 
(1997) and CAST (1994) estimated the affected USA population at 20%. Hitchins 
(1996) estimated ..... (TR to complete) 
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Appendix C Complete data set for bacterial thermal inactivation 
Bacterium Strain(s) Medium 
E. coli 
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Initial 
Cell 
Count 
Surviror D value 
Temp Time (s) s (s) Z-value 
121 
Reference 
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ground-Jamb 
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Salmonella 
Listeria 
monocytogenes 
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Y. e11terocolitica 
C. j ej1111i 
C. co/i 
B. cereus 
B. 
stearothermophi/ 
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Appendix D NSW Survey Results (raw data) 
Factory 
Al 
A2 
BI 
B2 
B3 
B4 
B5 
B6 
B7 
c 
D 
E 
F 
G 
H 
I 
J 
L 
M 
N 
0 
p 
QI 
!section 1 Milk and Dairy Products 
Pasteurised Cheese wt th Yoghurt and . Refngerated Ice Frozen tee . 
Itqutd milk (L) Cheese (kg) Moisture >40%, cultured dairy Milk powder Cream (kg) cream mixes cream and Datry . 
pH >5.0 (kg) products (kg) (tonnes) (eg. Soft serve) related products desserts/dips 
732,000 
66,000,000 
40,500,000 2,300,000 
200,000,000 
13,000,000 
200,000 
I80,000 
100,000 
170,000,000 
200,000 
1,200,000 
5,000 
200 
12,500 
(L) (L) (kg) 
1,500,000 
2,000,000 
850 3,000,000 I ,700,000 
I 7,800,000 
47,500 4,800 
6,200 
NB-->> 
25,000 
+ 
I05,000 
+ 
4,900,000 
Sweetened 
condensed butter (kg) 
milk (L) 
8,000,000 
I,000,000 
I ,000,00 
0 
Other 
I0,000,000 
76,000,000 
17,800 
Flavounngs 
Fat 
2,880,000, 
000,000 
NB-->> 
129 
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Q2 
R 8,000 
Sl 28,000,000 
S2 33,800,000 320,000 
T 6,300 
u 840,000 
v 300,000 115,700 510,000 450,000 
w 15,000 
x 300,000 
y 24,000 
z 6,400 10,000 
AA 233,862 
AB 25,000 
AC 2,000 10,000 4,500 26,000 
AD 70,000 
AE 25 35 
AF + + + + 
AG 50,000 
AH 20,000 
Appendices 131 
Section 2 Farm MilK Pickuo 
Compliance farm Max 
Factory Number of Herd size of farms milk temperature Milk 
Supplying Exact number (<40C) temp 
farms 1 to 20 21-50 51-80 81-100 101-150151-200 201-250251-300301-350 351-400 401-500 500+ Summer/ Winter/ Sorinl! Autumn 
Al 
A2 
Bl >100 95 - 100 95 - 100 15 
B2 20 - 40 30 4 4 7 6 4 3 2 90 - 95 95 - 100 38 
B3 60 - 80 65 5 30 20 10 95 - 100 95 - 100 10 
B4 >100 20 
B5 >100 300 6 30 30 40 30 20 10 5 5 3 3 80 - 90 90 - 95 8 
}l6 20-40 23 15 
B7 0 
c -
D >100 127 3 0 56 46 39 20 2 2 5 I 90 - 95 95 - 100 10 
E 
F 
G 1 to 20 1 1 95 - 100 95 - 100 4 
H >100 273 
I 
J -
K 
L 
M 
N 
0 
p 
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QI 20 - 40 30 95-100 95-100 15 
Q2 80-100 86 6 40 10 20 3 6 1 95-100 95-100 6 
R 
Sl 
S2 60-80 68 95-100 95-100 4 
T 
u 1 to 20 3 95-100 95-100 4 
v 
w 
x 
y 
z 
M I to 20 1 95- I 00 95-100 4 
AB 
AC 1 to 20 1 1 95-100 95-100 4 
AD 
AE 
AF 1 to 20 18 6 9 3 95-100 95-100 4 
AG 
AH 
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Milk Intake 
Section 3 
Factor Total intake 
milk temperature at intake age of milk at I y (12 months) pasteurisation 
0-2 2 to 4 4 to 6 6 to 8 8 to 10 > 10 Min Max Average 
Al 
A2 1,350,000 15 80 5 
BI 105,000,000 98 2 24 60 30 
B2 20,916,354 I 93 5 I 41 66 60 
B3 76,000,000 95 4 I 
B4 200,000,000 99 1 28 72 
B5 200,000,000 80 20 8 72 48 
B6 2,300,000 98 2 40 64 52 
B7 60,000,000 97 3 42 72 60 
c 13,000,000 100 46 96 72 
D 183,000,000 5 90 5 1 48 24 
E 
F 
G 200,000 100 1 48 24 
H 40 64 48 
I 
J 96,000 80 90 
K 144,000 90 10 
L 
M 
N 10,000 
0 
p 
QI 185,000,000 100 24 72 55 
02 52,000,000 98_ ·2 
R 
SI 
S2 33,078,190 85 15 45 70 60 
T 
u 5,200,000 0 72 
v 6,200,000 100 24 72 48 
All mix received solid frozen - All Min temp 
w 1,600 units sold solid frozen -20C 
x 
y 2,000,000 95 5 2 4 3 
z 23,000 90 10 
AA 240,727 10 90 28 78 39 
AB 
AC 40,000 50 50 2 48 12 
AD 17,000 70 25 5 
39,000 
AE 
AF 50 50 20 72 
AG 40,000 
AH 150,000 
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!Section 4 Pasteurisation 
Factory Number of Pasteurisers I 
Batch HTST Operating Temp Diversion Valve Holding time temp (s) 
Al 
A2 1 90 84 360 
B1 2 78 75 15 
78 75 15 
B2 1 / 77 74 I8 
B3 
B4 5 74 73 I5 
74 73 I5 
80 78 25 
78 76 O.I 
78 76 I5 
B5 0 5 75 -79 74 I5 
75 - 78 74 I5 
75 - 78 74 I5 
74-78 74 I5 
78 - 80 78 25 
B6 0 I 84 78 20 
B7 92 90 900 
92 I 82 90 I 80 900 
I43 134 4 
c I 75 72 23 
D I 74 72.5 I6 
E 
F 
G I 72 - 900 
I 73 -77 72.5 20 
H I 75 72.6 I7.5 
I 
J 
K 
L 
M I 
N 
0 
p 2 I 80 - 600 
QI 3 76 74 28 
76 74 26 
80 76 27 
02 
R j 
SI I 85 79.5 26 
S2 2 75-76 72.5 33 
75-78 72.5 29 
T 
u I 75 72.5 17 
v I 85 I800 
I 74 72.6 40 
w 
x 2 4C - 72C 30 
y I 78 72.5 15 
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z 
AA 2 140 138 16 
140 138 16 
AB 
AC 4 65 1800 
90 
80 15 
72 15 
AD 
AE 
AF 77-79 74 35 
AG 
AH 2 85 900 
90 900 
l 
l 
·' 
\ 
'' 
Section 5 Transfer of Milk 
Number of 
Factory Transfer of products to other factories Factories sent 
to 
Raw Milk (L) Raw Cream Past. Milk (L) Past. Cream Other(L) (L) (L) 
Al 107,000 2 
A2 
BI 10,000,000 5,000,000 4 to 7 
B2 14,125,093 6,791,261 4 
B3 76,000,000 8 
B4 39,000,000 1,800,000 20,000,000 3,000,000 16,000,000 4 
B5 2,000,000 2 
B6 1,800,000 4 
B7 
c 
D 51,000,000 8 
E 
F 
G 
H + + skim milk up to 8 
I 
J 
K 
L 
M 
N 
0 
p 
Ql 3,200,000 1,250,000 8 
02 52,000,000 1 
R 
Sl 
S2 
T 
u 
v 300,000 2 
w 
x 
y 
z 
AA 
AB 
AC 
AD 
AE 
AF 3,000,000 3,000,000 2 
AG 
AH 
Section 6 of the data from the questionnaire has not been included as the 
information contained within s considered of a sensitive nature. 
